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INTRODUCTION 
The Biomedical Engineering Program at Iowa Sta'ce Univer­
sity is investigating means for regulating artificial heart 
devices. One area of interest in this project, which uti­
lizes dogs as the experimental animal, is the study of tissue 
changes which might be associated with the implantation and 
maintenance of life with such a prosthesis. 
Two likely causes of lesions under these circumstances 
would be abnormal oxygen and carbon dioxide tensions in the 
blood either during or after surgery. Because the central 
nervous system (CNS) is one of the organs most sensitive to 
such insults and plays a vital role in homeostasis, it was 
decided to concentrate the study on the brain. 
Ic was necessary; therefore, to find a way to assess the 
state of health of the brain of a survival research animal. 
Serum enzymes have been used extensively for the detection 
of cell and organ damage, and it would appear that their 
detection would be a rational approach to this problem. 
Since most commonly used serum enzymes have their 
origin in a great variety of tissues, their elevation is not 
directly associated with damage to a particular organ. In 
order that the parameter chosen is a reflection of brain 
damage, a CHS-specific enzyme should be utilized. Glutamate 
decarboxylase (GDC) appears to be such an enzyme. 
The object of this study is to produce hypoxic brain 
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damage and to évalua-c the usefulness of serum GDC levels in 
detecting and assessing fhis damage. In addition, it might 
indicate whether this parameter is worthy of further study 
for its possible application, in either the research or the 
clinical laboratoryj, to other types of brain damage. 
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LITERATURE REVIEW 
Enzymes and the Detection of Cell Damage 
The clinical use of serum enzymes as a diagnostic aid 
indicative of cell or organ damage was initiated by Kay's 
work (1929; 1930). He found that serum alkaline phosphatase 
levels were elevated in patients with bone disease or with 
bile duct obstruction. Since that time many enzymes have 
been studied and evaluated for their diagnostic applicability. 
'[•Jhlte (i960) divided the clinically useful enzymes into 
two groups; (1) those that have a high degree of organ spec­
ificity and (2) those that have a wide distribution through­
out the body. The latter group included the majority of 
those studied such as glutamic-oxalacetic and glutamic-pyru­
vic transaminase (GOT and GPT), lactic dehydrogenase (LDH), 
isocitric dehydrogenase (LCD), aldolase and phosphohexose 
isomerase (PHI), and many others. Since they were found in 
so many tissues, interpretation of increased serum levels 
Was very complex. 
The list of organ specific serum enzymes is relatively 
small. It includes alkaline phosphatase (Kay, 1929 and 1930), 
acid phosphatase (Gutman and Gutman, 1939a and 1939b), amy­
lase (Elman and McCaughan, 1927; Elman, et al,, 1929), orni­
thine carbamyl transferase (Reichard. 1957a and 1957b) and 
alcohol dehydrogenase (Wolfson et al., 1959). These enzymes 
are soluble and are concentrated in a few tissues, damage to 
which is associated with elevated serum levels (Nickell 
and Allbritten1957; White, 1960) and lowered tissue levels 
(Zierler, l958a and 1958b; white, 1959; Pearson, 1956) of 
the enzyme. 
Enzymes are not manufactured in one site and transported 
via the circulatory system to another for intracellular 
function. Rather their presence in che serum in "normal" 
levels is the result of a "normal" rate of cellular degen­
eration, i.e., they are a product of cell "wear and tear" 
(Zierler, 1958a). VJhen the rate of normal degeneration is 
exceeded to the point of being pathologic, the rate of en­
zyme release into the serum is likewise increased. 
Glutamate Decarboxylase 
Function of the enzyme 
GDG catalyzes the conversion of glutamic acid to gamma 
amino-butyric acid (GABA) (Roberts and Frankel, 1950a and 
1951). pyridoxal phosphate acts as the coenzyme for the 
reaction (Roberts and Frankel, l950b and 1951). 
Conn and Stumpf (1966) gave the general reaction sequence 
for Che decarboxylation of amino acids with emphasis on the 
role of pyridoxal phosphate. 
That a Schiff^s base is formed in the GDC reaction has 
been confirmed by Duhault et al. (1966)= Anderson and Chang 
(1965) have shown by reduction with borohydride chat pyri­
doxal phosphate binds as a Schiff's base to zhe epsiion-amino 
group of a iysyl residue au the active site of GDC at a pH 
below 5. They found that in the physiological pH range the 
binding is of a nature which is resistant to borohydride 
reduction. Further at the higher pK only about 50% of the 
enzyme activity is lost after incubation with borohydride. 
These studies were conducted on GDC of bacterial origin. 
The bacterial enzyme differs from t'he brain enzyme not only 
in regard to pH-optimum and Km (Michaelis constant) values 
but also in that the brain enzyme is inhibited by CI" and 
other anions while the bacterial enzyme is activated by 
anions (Shulcuya and Schwert, 1960). 
Significance of the ^lutamste-GA3A system 
A detailed review of the innumerable studies which sought 
to clarify the role of the glutaraate-GABA system is outside 
the realm of this study. Excellent reviews of the material 
have been presented by I-Cillam (1958), Elliott and Jasper 
(1959), Roberts et al. {i960) and Roberts et al. (1964). 
Because "chis study does involve an important enzyme of 
the system.^ ic seems that a sample of the literature concern­
ing the function of the system should be presented. 
Among mammalian tissues, GDC and GABA are found in 
appreciable amounts only in the CNS and there it is almost 
entirely confined to the grey matter (Albers and Brady, 1959; 
Lowe et al., 1958; Muller and Langeman, 1962; Roberts et al., 
1958; Roberts et al.. 1964 and Salganicoff and De Robertis, 
1565). Together glutamate and GABA account for half the 
total (potential) alpha-amino nitrogen present in the brain 
(Ochs, 1965). 
The system is in essence a side route of the tricarb­
oxylic acid (ïGA) cycle for the formation of succinate from 
alpha-lceto g lut ar ate. Alpha-iceto g lut ar ate is arninated to 
form glutamate which then is decarboxylated by GDC to form 
GABAo GABA can be transaminated with more alpha-keto gluta° 
rate to form succinate semialdehyde and more glutamate. 
Succinate semialdehyde is then hydrated to form succinate 
(Killam^ 1958 and Roberts et al., 1958). The possibility 
has been suggested that major importance may be attached to 
this pathway as an energy source at particular cytological 
loci (Salvador and Albers, 1959). 
Host studies have been concerned with the possible role 
of GABA as a central nervous system (CNS) inhibitory substance 
and in chis regard there are differences of opinion^ 
Elliott and Jasper (1959) concluded that there can be 
little doubt that GA3A or a closely related substance is con­
cerned with regulation or transmission of nerve impulses in 
the central grey matter. It was also evident that depletion 
of QA3A is associated with hyperexcinability while exogenous 
GABA results in a depression of certain forms of brain activ­
ity. It was the exact nature and site of its action which 
Grundfest (1958) suggested that GABA selectl-vely blocks 
depolarizing (excitatory) synapses. Salganicoff and De 
Robertis (1965) speculated that GABA produced in the ACh-
poor (inhibitory) nerve endings; 
could either be collected in the axoplasm of the 
ending, flowing trans-synaptically to regulate 
in a non-specific way the excitability of the 
other neuron, or be deposited within synaptic 
vesicles to be delivered in quantal units at the 
arrival of the nerve impulse. 
The concept of GABA as a specific transmitter substance 
at inhibitory synapses was viewed cautiously by some (Elliott 
and Jasper, 195-9; Kirsch and Robins, 1962 and Killam^ 1958). 
Hirsch and Robins (1962) stated that there is no direct evi­
dence for and much indirect evidence against this concept. 
An alternate hypothesis is that GABA acts as an inhibitor in 
some non-specific manner. According to Sytinsky and Priyat-
kina (1966), GABA must not be considered an "inhibitory 
agent.'' Rather they regarded it as playing a -regulatory 
role influencing excitatory and inhibitory states by means 
of formation of a general inhibitory background to the cortex 
Glutamate has been observed to cause membrane depolariza 
tion which may initiate a spike potential (Curtis et al., 
i960). The possibility is open that regulation of nervous 
activity may be a balance between glutamate and GABA levels 
(Takeuchi and Takeuchi, 1964). Susz et al. (1966) suggested 
as possibility that variation of CI" content of a given 
nerve ending may regulate the glutamate and GABA concentra­
tion (via Gl" effect on GDC) of the ending. This in turn 
determines which is released in greatest concentration and 
thus whether or not the nerve has excitatory or inhibitory 
function. However, Eccles (l9ô5) emphasized that excitation 
and inhibition cannot result from the action of a single 
presynaptic neuron. 
Location of GDC 
Gross Lowe et al. (1958) found that the GDC activity 
of the monkey brain was highest in the globus pallidus and 
compared to this structure the activity of the superior 
colliculi was 63%; hypothalamus, 61%; visual cortex, 55%; 
putamen, 49%; head of caudate nucleus, 48%; motor cortex, 
40%. The activity of the cerebellar cortex was 85% that of 
the motor cortex. The activity of the granular layer of the 
cerebellum was approximately 20% higher than the molecular 
layer. There was a marked variation between the species they 
studiedo 
Albers and Brady (1959) also using monkeys found 12% 
higher activity in the utolecular than the granular layer of 
'Che cerebellum. They found that the activity was highest in 
the hypothalamus and mesencephalon, followed closely by the— 
thalamus, occipital cortex, cerebellum and motor cortex. The 
substantia nigra also had high levels. 
Kuller and Langeman (1962) found the highest levels of 
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GDC in the human brain were in areas belonging to the extra­
pyramidal motor system (palliduni, dentate nucleus > substantia 
nigra5 pre- and postcentral gyri and head of the caudate 
nuclei)o The cerebral cortex had about 50% as much activity 
as the pallidum. 
Each of these three groups found negligible activity in 
the white matter» 
Subcellular Balazs et al. (1966) reported that GDC 
had a bimodal distribution in the cell; partly in the super­
natant fraction and partly in particles. They inferred that 
the particles were nerve endings and not free mitochondria. 
The results of Salganicoff and De Robertis (1965) sug­
gested to them that GDC is located in AGh-poor nerve ending 
axoplasm loosely bound by Ca'""^ to membranes, especially 
synaptic vesicles. They said that GDC is a soluble enzyme. 
Van Kempen et al. (1965) found GDC in both the mito­
chondrial and supernatant fractions. However, they found, 
by gradient centrifugation^ striking heterogeneity of brain 
mitochondrial fractions as compared to those from heart and 
liver. They felt that this might be; 
explained either by presuming that many different 
types of particles do occur or by postulating a 
heterogeneity within one type of intracellular 
structures, for instance, mitochondria. 
They also thought that; 
The intracellular localization of GAD (GDC) seems 
CO differ from that of the other enzymes assayed, 
as indicated by the continuous shift of the GAD-
pealc by prolonging of the centrifugation, suggest­
ing the existence of a typical "GAD-particle", 
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Silatunova and Sy tin sky ( 1964) found most of the GDC 
activity in their low speed (800 g) and mitochondrial 
fractionso However, they admitted that the mitochondrial 
fraction v/as contaminated with nerve endings, microsomes 
and myelin fibers. They found no GDC activity in the 
nuclear (low speed) fraction when the latter was isolated 
in hypertonic sucrose solution. 
Hypoxic Brain Damage 
Methods of production 
Several methods have been reported for the production 
of brain anoxia. Thorner and Lewy (1940) produced vas­
cular and degenerative changes of the brains of guinea pigs 
and cats by forcing them to inhale nitrogen for sublethal 
periods of time. Weinberger et al. (1940a and 1940b) pro­
duced dramatic signs of central nervous system (GNS) dis­
function and brain lesions in cats by clamping the pulmonary 
artery. These methods produced total body anoxia» 
Other methods attempted to produce a more localized 
anoxia) i.e., to the head. These necessarily involved oc-
— elusion of arteries supplying the head, or specifically 
the brain. 
Blood is supplied to the brain of the dog via the in­
ternal carotid arteries and the basilar artery. The basilar 
artery is supplied by the ventral spinal artery and the 
cerebrospinal artery, Almost all the blood reaching the 
brain via the latter two vessels has previously been supplied 
by the vertebral arteries„ The ventral spinal can potentially 
send blood to the brain which it attained from any of its 
intervertebral contributors in the thoracic and lumbar areas. 
There is an anastomotic branch (ramus anastimoticus) between 
the occipital branch of the external carotid artery and the 
vertebral artery (Miller et al», 1964). 
Gildea and Cobb (1930) used various combinations of 
ligating the four major vessels supplying the brain, i.e., 
the two vertebral and two com-r.on carotid arteries ^ They were 
unable to produce complete anemia or a predictable response. 
Bunce (l96l) simultaneously ligated and sectioned both 
common carotid and both vertebral arteries in dogs. Immed-
ia.te signs of CNS dis function were usually not dramatic. He 
concluded the the ventral spinal artery must have been supply­
ing sufficient blood to the brain to support life immediately 
following the operation and that other collateral pathways 
became furictional later. His cozic lus ions were supported by 
vfnisnant et al. (1956) who found that collateral circulation 
between the costo- and omocervicals and the muscular branches 
of the vertebrals was not present immediately after both 
common carotids with their terminal branches and both verte­
brals had been ligated, but developed v/ithxn 46 days after 
ligation and supplied the brain with adequate blood. No 
collateral circulation developed to the common carotid ar­
teries „ 
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Coir.plote brain anemia can be produced by ligation of 
the basilar artery and common carotid arteries in the cat 
(Pollock and Davis^ 1923) and in the rabbit (Ames et al., 
1968)^ In the dog, the inaccessibility of the basilar ar­
tery raakes this a difficult method (Kabat and Dennis, 1938). 
Thomas et al « (1965) devised a new method for the pro­
duction of reversible long-term brain ischemia in dogs. With 
a dacron vessel prosthesis they exteriorized the route of 
blood flow to the neck and head. They were then able to 
interrupt the flow at will. The method required surgery 
involving transverse thoracotomy. 
Kabat and Dennis (1938) briefly outlined a method for 
the production, in dogs, of complete, temporary brain anemia 
(ischemia) in the absence of anesthetics. It provided for 
the occlusion of the ventral spinal artery» They surgically 
removed both laminae and spine of the axis and ligated both 
vertebral arteries. After one or two weeks they inserted an 
endotracheal tube, vzrapped a blood pressure cuff around the 
neck and rapidly inflated it to a pressure of 350 mm Hg. 
In a report the following year (Dennis and Kabat, 1939), 
some modifications of the technique were given; ischemia was 
produced only two days after surgery, a metal endotracheal 
tube was used and the pressure applied around the neck was 700 
mm Hg. With this technique, consciousness was lost in a few 
seconds, corneal reflex disappeared in 20 to 40 seconds and 
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respiration ceased in 40 to 50 seconds and had co be con­
tinued artificially. These responses occurred much sooner 
than with the original method. This technique has been re­
ported to produce constant effects from animal to animal 
(Grenell, 1946). 
They later reported (Kabat et al., 1941) that dogs which 
had been subjected to arrest of brain circulation for six 
minutes or less, recovered nervous f'unction completely while 
those receiving the treatment eight minutes or longer in­
variably suffered permanent CNS damage, 
For convenience they divided the recovery into six 
periods. (l) Period of early return to f-unction; this was 
apparently the first 30 to 60 minutes after blood flow was 
reestablished. During this time the animal remained in coma 
and was flaccid. Spontaneous respiration usually began in 
one to two minutes and the wink reflex usually returned in 
four to six minutes in dogs in which ischemia was miaintained 
six minutes or less. (2) Period of hyperactive coma; per­
sisted for several hours and included rapid coordinated run­
ning movements with the legs intermittent with leg and 
neck extensor rigidity and tightly closed jaws. (3) Period 
of quiescent coma: persisted for 12 to 24 hours in dogs 
receiving treatment for eight m.inutes or more. There was no 
spontaneous movement and the threshold to noxious stimuli 
was greatly elevated. The limbs and tail were flexed, the 
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neck rigid and the head moderately extended. Despite the 
coma J the dog would lap mechanically when its mouth was 
placed in milk. (4) Period of apathy and severe ataxia; 
dogs which survived arrest of brain blood flow for eight 
minutes or longer never recovered to this phase. In the 
other dogs, this was the period of early recovery of function 
of the higher centers. The dog would roll from his side to 
the sternum. Flexor rigidity was disappearing. Spontaneous 
movement consisted at first of licking, sitting up, turning 
the head and attempts to crawl. For a brief period, visual 
or auditory stimuli elicited a type of "sham rage". Later, 
the animal began to stand and walk with extreme ataxia and 
had a tendency to step on the dorsum of the forepaws. Food 
was recognized and eaten but there was no response to other 
animals. (5) period of residual ataxia; the animals had 
regained the ability to perform formerly taught tricks 
without relearning them. Ataxia was mild and falling in­
frequent. (6) Recovery; there was no residual brain damage 
as could be determined by routine neurological examination. 
The authors did not employ special techniques for the examina 
tion of higher cerebral functions. 
Age resistance to hypoxi c brain damage 
Selle and Wit ten (1941) studied the survival of the 
primitive respiratory mechanism after anoxia in various age 
rats and found that the respiratory center of young rats is 
much more resistant to anoxia than it is in older animals. 
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Salle (l94l) extended the study to spinal reflexes, pupillary 
responses and heart action in rats, rabbits and dogs and found 
a similar resistance of these functions to anoxia in the young 
of these species, 
Kline and Britton (1945) reported that fetal or newborn 
Cats, dogs and opossums survived much longer at 320 iriin Kg 
atmospheric pressure than older animals. It was not until 
about weaning age that the short survival time typical of 
adults was approached by the young. 
EderStrom (1959) found that dogs 10 days old or >ounger 
had higher survival rates than older animals when subjected 
to rapid blood loss averaging 5.4% of body weight. 
Kabat (1940) using his technique for the production of 
complet-e temporary ischemia was able to show that the brain 
of the young animal is much more resistant to arrest of its 
circulation than the adult organ and that this resistance is 
reduced to the adult level at four months of age in the dog. 
Dravid and Jilek (1965) felt that the resistance of the 
young to anoxia was related to the greater ability of the 
young brain to more efficiently utilize its stores of gly­
cogen as a substrate for anaerobic glycolysis than the adult. 
Pathology 
Area susceptibility Certain areas of the brain are 
more susceptible to anoxia than others, Grenell (1946) indi­
cated that there seemed to be a certain order in which the 
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various parts of Che CNS are affected by circulatory arrest, 
i.e., there is a gradient of tissue response. In his own 
work, he found the cerebral cortex was most sensitive, follow­
ed by the purkinje cells of the cerebellum and the cerebellar 
nuclei. Beyond this the order was not as clear cut but 
seemed to be^in decreasing order of susceptibility: the 
sensory and integrative centers of the brain stem, pons and 
medulla oblongata and finally, the large motor cells of the 
brain stem, pons, medulla oblongata, and spinal cord, 
Gomez and pike (1909) found the small pyramidal cells 
of the cerebral cortex to be the most sensitive with the 
Purkinje cells of the cerebellum, ceils of the medulla, cervi­
cal portion of the spinal cord and spinal ganglia following 
in that order. 
The gradient as reported by Weinberger et al. (1940) 
was cerebral cortex, purkinje cells of the cerebellum and 
basal ganglia, with greatest resistance shown by both spinal 
cord and medulla oblongata. 
Levine (1960) stated that the hippocampus was the most 
vulnerable structure, and that gray matter was generally 
more vulnerable than white matter « Lucas and Strangeways 
(1963a and 1963b) also felt that the hippocampus was the 
most sensitive structure to anoxia. 
Kicroscooic Grenell (1946) produced brain circula­
tory arrest in dogs using the technique of Dennis and Kabat 
(1939) and studied the resulting histologic alterations of 
the brain. He minimized post mortem autolysis by perfusing 
the brains with fixative at death. He found striking vas­
cular changes which increased in severity with increasing 
duration of ischemia. The changes in blood vessels were 
dilation, congestion^ distortion, endothelial reaction, 
collapse and perivascular edema. With long-term ischemia, 
few patchy areas of vascular proliferation were found. 
Lesions in the cerebral cortex were accompanied by 
profound vascular changes. Cortical alterations were of 
similar nature regardless of ischemia time, but the number 
of cortical areas injured and extent of injury within each 
area varied directly with the duration of ischemia. Changes 
with two minutes of ischemia were vascular and cellular 
in nature and were primarily restricted to Laminae III and 
IV, Longer ischemia periods produced changes in Laminae II 
The cortex had a punched-out appearance in some areas 
in which only faintly stained, chromatolytic neuron remnants 
were found sometimes with some glial cells. In other areas 
there was a more diffuse gliosis, satellitosis, chromatolysis 
neuronophagia, occasional vacuolated neurons and swollen 
neurons. Distorted neurons with various degrees of shrink­
age were most numerous. Some cell bodies formed angular 
corners with their processes, or had sharply pointed or 
lengthened cytoplasm. Often the cell was devoid of its 
nucleus. The most severely injured cell had dark (with 
Nissl stain) homogeneous cycoplasm, Perineuronal edema and 
laminar disorganization were common findings. 
After eight minutes of circulatory arrest, the brain 
alterations were more generalized as well as having more 
severe injury to areas with the greatest degree of suscepti­
bility. Specific cell changes mentioned by Grenell included 
hypertrophy of some of the vascular endothelium and dis­
appearance of many of the Purkinje cells, leaving holes which 
were partially occupied by neuroglia. Chromatolysis of many 
neurons of the red nuclei occurred leaving "shadow" or "ghost" 
cells with satellitosis and neuronophagia. 
Luca^ -and Strangeways (1963b) used several methods to 
produce brain damage and studied the nature and progression 
of nerve cell changes of the hippocampus. They were able 
to confirm that cellular damage is the same irrespective of 
the method of anoxia production. 
The first neuronal changes found during the first two 
days were real or apparent shrinkage with the presence of 
irregular pericellular spaces. The cytoplasm was still baso­
philic and the nucleus became small and irregular ("Nissl's 
chronic cell change"). During this time, they had trouble 
distinguishing these changes from the post mortem artifacts 
found in their controls. By the third day the changes were 
definitely real. The nuclei became round but were still 
basophilic, the Nissl granules had disappeared and the cyto­
plasm became intensely acidophilic ("Nissl's ischemic cell 
change"). Some of these cells gave rise to "Spielmeyer's 
homogenizing change" in which the nuclei became acidophilic 
and cytoplasm apparently disappeared. 
From the third day severely damaged cells were surrounded 
by large round spaces. This lesion was maximal from the third 
to fifth days and then diminished. Cell loss was first no­
ticed on the fifth day and reached maximum during the next few 
days. After 14 days, only an occasional acidophilic cell was 
found and the neurons that remained appeared to be recovering 
their normal structure. Gliosis was less marked than during 
active cell destruction. The cell loss which would occur 
was completed by the seventeenth day and recovering cells 
were nearly back to normal. 
The authors felt that the classical alterations of 
brain architecture ascribed to anoxia were not separate but 
progressing entities, i.e., first there was Nissl's chronic 
cell change followed by ischemic cell change of Nissl and 
finally, Spielmeyer's homogenizing change. They felt the 
latter represented the irreversible step. 
They interpreted small irregular pericellular spaces 
as artifact but never found the large spherical spaces in the 
controls. They thought that these spaces were probably 
large swollen oligodendroglial cells. 
20 
Ames et al. (1968) found that rabbit brains, subjected 
to brief periods of total ischemia, developed areas which 
remained ischemic even after circulation was restored. They 
called this the "no-reflow phenomenon." Studying this same 
material with the light and electron microscopes, Chiang et 
alo (1968) found that the most important change was swelling 
of the perivascular glia. This was of much greater degree 
than found in the controls. They also found "cellular blebs" 
connected to endothelial cells projecting into the vascular 
lumen. These developed during the ischemic period but were 
larger 30 minutes later. They proposed that: 
the perivascular cells became swollen because of active 
sodium transport failure (on account of the ischemia), 
that the water responsible for this swelling came 
largely from the plasma, and that this led to an 
increase in blood viscosity, which also contributed 
to impairing the return of blood flow. 
Ultramicroscopic and chemical Webster and Ames 
(1965) have subjected rabbit retinas to deprivation of oxygen 
and/or glucose in vitro and studied the fine structural 
changes. Retinas deprived of glucose and oxygen for only 
three minutes showed generalized swelling of m.itochondria 
and changes of the synapses with loss of synaptic vesicles. 
Increasing the time of this deprivation intensified the above 
changes and also led to progressive swelling of the Golgi 
membranes and the granular endoplasmic reticulum. These 
changes became irreversible by 30 minutes, at which time 
multiple discontinuities had appeared in cell and organelle 
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membranes. It took somewhat longer to produce these changes 
with anoxia alone. Glucose deprivation alone produced only 
minor changes. 
Hager et al. (1960) found that the earliest change 
occurred in the endoplasmic reticulum. The membranes sepa­
rated and their continuities were broken. The ribosomes 
rarified or formed clumps. The most pronounced alterations 
occurred in the mitochondria. They became swollen and spheri~ 
cal, the internal membranes lost their parallel structure, 
fragmented and finally disappeared. The matrix loosened and 
became invisible. The mitochondria became membrane bound 
vacuoles. The authors suggested that hypoxia resulted in 
chemical changes which increased the intracellular osmotic 
pressure which in turn caused hydration of the cell and its 
organelles. 
Yap and Spector (1965) studied several intracellular 
enzymes in post-anoxic rat brains and found early losses of 
enzyme activity. In animals which were least affected by the 
anoxia, the activity of several dehydrogenases and diphospho-
pyridine nucleotide (DPN) diaphorase returned except in 
regions of neuronal destruction, Neurons which had the 
greatest change contained increased amounts of acid phospha­
tase and decreased ribonucleic acid (RInA) content. They 
suggested as possibilities for the cause of enzyme loss and/ 
or cell destruction: (1) Failure of oxidative phosphorylation 
with subsequent deficiency of adenosine triphosphate (ATP) 
would lead to inhibition of energy-dependent activities of 
the cell such as water and electrolyte homeostasis, electri­
cal activity and protein synthesis. (2) Enzyme digestion 
and cell destruction could result from lysosomal enzymes 
liberated as a result of anoxic damage to lysosomal membranes. 
(3) Failure of ATP production following anoxia could result 
in breakdo^vn in RNA synthesis with enzyme loss. 
Becker and Barron (l96l) found enlargement and clump­
ing of lysosomes ("cytolysome" formation) during the early 
phases of autolysis and necrobiosis. Loss of lysosomes be­
came prominent during later phases. 
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MATERIAL AND METHODS 
Experimental Design 
The experimental design was generated as a result of 
a joint effort between the author and a statistician^and 
was based upon some preliminary studies, 
The experiment was divided into two phases. In Phase 
1 the steps for the production of hypoxic brain damage (to 
be subsequently described) were conducted on different days. 
The production of complete brain ischemia followed the 
preparatory surgery by 7.5 days. In Phase 2, the procedure 
for the production of brain ischemia (hereafter referred to 
as ischemia) was conducted on the same day as surgery, about 
six hours after the dog had recovered from anesthesia. 
A blood collection schedule was made for Phase 1 which 
included 10 baseline (presurgery), 12 post-surgery (P-S) 
and 13 post-ischemia samples. Phase 2 sampling was basically 
the same except there were no P-S and 14 post-ischemia 
samples. The baseline samples, which were taken to establish 
normal serum levels of enzyme activity, were drawn at daily 
intervals. Table 1 gives the details of the sampling schedule. 
^Dr. David Jowett, Associate professor of Statistics, 
Department of Statistics, Iowa State University^ Ames, Iowa. 
Exoerimental design of experiment, private communication. 
1967. 
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Table 1. Blood sampling schedule 
Phase 1 Phase 2 
Hours after 
Hours post- brain Hours after 
Sample numbers surgery ischemia brain ischemia 
1-10 Baselines Baselines 
11 6 CXI oo KB tm 6 
12 12 — — — 12 
13 24 24 
14 36 36 
15 48 48 
16 60 — — — — 60 
17 72 H M» MB 72 
IS 90 M 90 
19 108 108 
20 132 — — — — 132 
21 156 — — — — 156 
22 180 — — — — 180 
23 186^ 6 204 
24 192 12 228 
25 204 24 
26 216 36 — — — — 
27 228 48 
28 240 60 mm am tarn ^  
29 258 78 M H ^  M 
30 276 96 •M «H M M 
31 300 120 — «a — 
32 324 144 = — * — 
33 348 168 
34 372 192 
3i 396 216 " - — — 
The design called for blocki .ng the experiment. E, 
block was identical and consisted of four treatments- With­
in each block. Treatment 1 consisted of two dogs on which 
the entire surgical procedure was performed and followed 
25 
Table 2. Experimental design 
Phase 1 phase 2 
Block Block 
Treatment 1 2 3 4 1 2 
I Brain ischemia 211 
221 
212 
222 
311 
321 
312 
322^ 
411* 
421 
412* 
422 
II Surgery control 231 232 331 332 431 432 
III Laminectomy control 241 242 341 342 441 442 
IV Anesthesia control b 252 351 352 451 452 
^Died during ischemia procedure. 
°There was no dog for block 1, Treatment IV as this 
control was instituted after block 1 was started. 
by ischemia. Treatment II was the surgery control and con­
tained one dog per block. The entire surgery was conducted 
for this treatment but the ischemia procedure was omitted, 
Ischemia was,likewise, omitted for Treatments III and IV, 
each of which contained one dog per block. For Treatment 
III the vertebral artery ligation was omitted from the 
surgical procedure and was, therefore, the laminectomy con­
trol. Treatment IV was the anesthesia control since no 
surgery was performed. Anesthesia was induced and miaintained 
for 80 minutes. 
Phase 1 contained four blocks and Phase 2 had two. All 
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animals of a single block were started and carried through 
the experiment at the same time» 
Table 2 depicts the experimental design and indicates 
the animal numbers for each block and treatment. 
Experimental Animals 
The experimental animals were purebred Beagle dogs of 
both sexes. They were five to six months of age. A source^ 
was found which could supply healthy dogs of the proper age 
at the desired time. They had been vaccinated for canine 
distemper and infectious canine hepatitis and treated with 
taeniacidal and ascaricidal drugs. 
The first consideration in selecting dogs for a block 
was age. The next consideration was uniformity of size. 
The subsequent treatment assignments were random. 
Production of Hypoxic Brain Damage 
Using the brief descriptions of Kabat and Dennis (1938) 
and Dennis and Kabat (1939) for the basic idea, complete 
temporary brain ischemia was produced in the following manner. 
The method required preparatory surgery followed by the 
actual induction of ischemia. 
^Theracon, inc. Topeka, Kansas, 
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Phase _! 
Surr.ical Procedure Feed was withheld from the ani­
mals for 15 hours prior to surgery a Preanesthetic medica­
tion consisted of a subcutaneous injection of l/lOO grain a-
tropine sulfate 15 minutes prior to induction of anesthesia. 
Induction was with 4% sodium thiamylal^ to effect but not 
greater than 1 ml/2.3 kg body weight given intravenously. 
The trachea was entubated and anesthesia was maintained with 
methoxyflurane^ administered with a circle-type inhalation 
c 
anesthesia machine , 
The neck was clipped with a number 40 Oster^ blade from 
the shoulders to the temporal area of the head. Both rear 
legs were clipped, washed and disinfected from the hock to 
the stifle joints over the saphenous vein. The animal was 
placed in ventral recumbency in a V-shaped surgical trough. 
The front legs were retracted along the thorax and abdomen, 
and the head and neck were raised and stabilized with cloth 
rolls. 
A slow intravenous drip of 5% dextrose^ in water was 
started in the saphenous vein. 
^Surital^. Park, Davis, & Co., Detroit, Michigan, 
aetaphane^l Pitman-Ho ore (Dow Chemical), Indiana-
polis, Indiana. 
'^Heidbrink^t Kinet-o-meter, Ohio Chemical & Surgical 
Equipment Co., Hadison, Wisconsin. 
'^Cster Manufacturing Co., bïilwaukee, Wisconsin^ 
^Abbott Laboratories5 Chicago, Illinois. 
The surgical field was scrubbed with surgical soap 
which was followed by two applications of benzalkonium 
chloride^„ 
The surgical field consisted of an area 2 cm on each 
side of the dorsal midline from the middle of the first to 
the middle of the third cervical vertebrae. This field was 
outlined with sterile towels and by a fenestrated surgical 
drape. 
The skin incision was made over the axis. Subcutaneous 
hemorrhage was controlled with mosquito forceps and electri­
cal cautery. 
Kayo round blade dissecting scissors were used to blunt­
ly dissect through the median raphe between the rhomboldeus, 
splenius, semispinalis capitis (biventer) and rectus capitis 
dorsalis major muscles to the dorsal crest of the spinous 
process of the axis ^ Hemorrhage was controlled by two by two 
inch gauze sponges (2:c2's), pressure and natural coagulation, 
Vrnen the crest of the spinous process was exposed, the 
dorsal neck muscles were retracted with Gelpi retractors 
(Figure 1). The insertions of the multifidus cervicalis, 
spinalis and the origin of the rectus capitis dorsalis major 
muscles on the spinous process were transected with hayo 
scissors (Figure 2). The tip of a periosteal elevator was 
^Phisohe:-:'^. Winthrop Laboratories, New York, N.Y. 
/3\ 
°Zephiran chlorideU.S.P., refined, 1/750, Winthrop 
Laboratories, New York, N.Y. 
used to disengage and elevate periosteum and muscle from 
the process and arch of the axis (Figure 3}. 
Two Gelpi retractors were engaged, one at each end of 
the axis, into the medial surface of the periosteum on each 
side of the vertebra. The periosteum was retracted. 
A vertical cut was made in the spinous process about 
two mm from its anterior end with a Horsley double action 
double bent bone cutting forceps (Figure 4). This cut was 
placed so as to slightly involve the arch. Care was re­
quired not to rupture the intervertebral vessels (Ramus 
Spinalis 11) between the atlas and axis. 
A second cut was made diag onally from the ventral end 
of the first cut to the top of the spinous process at a 
point about one cm anterior to the posterior end of the 
process (Figure 5). When the triangular piece of spine was 
removed 5 a small aperature remained in the dorsal part of 
the vertebral canal (Figure 6)= 
In front of the aperature, the remaining arch would 
usually break loose from the ventral lamina leaving a poten 
tially dangerous osseous spike on each side of the spinal 
cord (Figure 6). Before further manipulation, the remainin 
anterior part of the dorsal process was grasped with hemo-
stats to retract the spikes away from the cord. They and 
remaining arch were removed with Ruskin rongeur forceps. 
The remaining spinous process was not removed at this time 
Figure 1 „ Upper ].efi:. Surgery. Right side r- anterior. Skin and dorsal neck 
muscles retracted and crest of spinous process exposed (arrow). 
Figure 2. Upper right. Surgery. Right side - anterior. Gutting muscle 
a11achraen!: s on spinous proces s „ 
I'igure 3c Lower left. Surgery.. Right side = anterior. Periosteum elevated 
and retracted exposing,process and arch of axis. 
Figure 4. Lower right. Surgery. Right side = anterior. Anterior vertical 
cut made in spinous process including small amount of arch, (arrow). 

because possible hemorrhage from this procedure would delay 
further surgery. 
With the opening in the roof of the vertebral canal, it 
was possible to surgically remove the anterior three cm of 
roof and dorsal lamina with bone rongeurs (Figure 7). The 
cord was exposed to a level of one to two mm dorsal to its 
horizontal midline (Figure 8). 
The vertebral arteries were accessible deeper in this 
surgical field on either sice of the vertebra just as they 
emerged from the transverse foramina anterior to the trans­
verse processes. 
The retractors were lowered again to engage periosteum 
at about the level of the cut edges of laminae. The trac­
tion on the periosteum pulled it away from the bone enough 
to create a field seven to eight mm square through which the 
artery passed. The artery was still surrounded by connect­
ive tissue at this point and barely discernible. 
Because of the danger of uncontrollable hemorrhage and 
the very restricted working space, a ligature could not 
simply be passed around the vessel. The vessel had to be 
exposed and undermined by blunt dissection (Figure 9), 
Introducing a closed straight mosquito forceps into the 
tissue and opening the jaws several times retracted the 
connective tissue and produced a small opening on either side 
of the vessel. Curved miosquito forceps were used to continue 
Figure 5, Upper lefC„ Surgery. Right side = anterior. Second (diagonal) 
bone cut about to be made with Hors ley bone cutter. 
Figure 6. Upper right. Surgery. Right side anterior. Triangular piece 
of bone removed from spinous process. The potentially dangerous 
spike (arrow) is also visible. Aperature in vertebral canal is 
behind spike. 
Figure 7. Lower left» Surgery. Right side - anterior. Removal of roof 
and lamina of vertebral canal with bone rongeurs. Spinal cord 
is visible. 
!• rgure 8 Lower right. Surgery. Right side = anterior. Spinal cord exposed. 
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the procedure under the vessel. Usually the undermining 
could not be safely completed with forceps. The thin 
connective tissue band which usually remained under the 
vessel was gently teased open and the aperature widened 
with a mall probe. 
To pass suture material around the exposed vessel, it 
was necessary to construct a hook which could be placed 
around the vessel. This was made by doubling and loosely 
twisting a 40 cm piece of 22 gauge stainless steel suture 
wire to form a one by two mm loop in the doubled end. The 
looped end was bent to form a three mm full curve. .A large 
loop was placed in the other end of the wire at a right angle 
to the hook to aid gripping and manipulation of the instru­
ment, The instrument was rigid enough to manipulate yet 
flexible enough to make it adaptable to the individuality 
of the surgical field. 
The hock was passed aro^ond the vertebral artery from 
posterior to anterior (Figure 10). A piece of 00 silk 
swaged to a needle^ was used as the ligature. The end of 
the needle was cut off so that only four mm of it remained 
swaged to the thread. The swaged end was grasped with a 
mosquito forcep and the free end passed through the loop 
(Figure 11). Another forceps was used to grasp the free 
end after which the grip with the first one was released. 
"^OO^black blaided silk (cardiovascular) wiuh tapered 
atraloc RB-1 needle. Ethicon, Inc. Somerville, liew Jersey. 
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One-haIf the length of the thread was then pulled through the 
loop and the needle was removed. The silk was raoistened and 
pulled around the vessel by gently disengaging the hook from 
around the vessel and slowly pulling it out of the incision 
(Figure 12) until equal lengths of thread were on each side 
of the vessel. 
Transection of the thread at the loop left two pieces 
of suture material around the vessel which were used to 
doubly ligate the artery. Ligation was accomplished by 
running each overhand knot of a square knot toward the 
vessel with mosquito forceps. The process was repeated for 
the vertebral artery on the opposite side. 
The final procedure before closure was removal of 
remnants of the anterior portion of the spinous process. 
Muscle closure was accomplished by apposing three 
layers: the multifidus cervicaliSj the biventer and the 
rhomboideus muscles, A simple interrupted pattern with 00 
silk was used. Subsutaneous closure was done with 00 silk 
with a continuous pattern. Medium weight synthetic poly-
filament suture material^ was used with a simple interrupted 
pattern to appose the skin edges. 
Brain ischemia production The dog which had been 
surgically prepared 7,5 days previously was given l/lOO 
^Vetafil bengen^l Imported by Dr. S. Jackson. 
Figure 9. Upper left. Surgery. Right 
exposed at its point of exit 
to the transverse process of 
side = anterior. Vertebral artery 
from the transverse foramen anterior 
the axis. 
Figure 10, Upper right. Surgery. Right side = anterior. Ligature passing 
hook in place around vertebral artery. 
Figure 11. Lower left. Surgery, Right side = anterior. Needle (with end 
cut off) passed through eyelet of hook. Thread swaged to needle 
is visible. 
Figure 12. Lower right. Surgery. Right side = anterior. Silk thread being 
pulled around vertebral artery. 
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grain atropine sulfate. Fifteen minutes later a topical 
anesthetic^ was sprayed in the area of glottis and epiglottis 
of the unanesthetized animal. After a one minute interval, 
a cuffed endotracheal tube was introduced into trachea and 
inflated. A cloth wrap to which a cloth roll (4 cm long 
by 1.7 cm in diameter) had been secured was wrapped around 
the neck and fastened with tape. The roll was positioned 
over the axial defect (Figure 13). 
A pneumatic cuff° was positioned around the neck over 
the VTTap and connected to pressure system (Figure 14). The 
cuff was inflated to 700 mm Kg pressure. The pressure was 
attained within a fraction of a second. 
The animal would usually lose consciousness. Respira­
tions would usually cease in three to five minutes but would 
often start again for a short time. A period of one minute 
c 
was allowed after breathing ceased before the respirator 
was connected to the endotracheal tube and artificial 
respiration initiated. This time period was necessary to 
confirm that respiration had ceased and would not start again 
without artificial respiration. The heart was monitored 
^Getacaine ^  spray. Kaver-Lockhart. Kansas City, Missouri.. 
^Kidde^conductive cuff, style 24. Available through 
V. Mueller, Chicago, Illinois. 
^Mark 8 respirator. Bird Corporation. Palm Springs, 
California. 
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during this procedure. 
The neck cuff was deflated and removed at desired time 
which Varied from nine to 20 minutes. The artificial respira­
tor was removed as soon as the animal was able to resume un­
assisted breathing. 
Phase 2 
Surgical procedure The Phase 2 animals had identical 
surgery as those in Phase 1. After Phase 1 surgery was com­
pleted, Treatment I animals of Phase 2 were turned over in 
the trough and the throat was prepared and draped for aseptic 
surgery, 
Â four cm incision was made in the midcervical area two 
cm lateral to the ventral midline. Using blunt dissection, 
the common carotid artery was located and separated from the 
surrounding fascia and vagus nerve. The vessel was brought 
to the surface and held with an Allis tissue forceps, A 
stab incision was placed one cm from the original incision, 
A 25 cm piece of six mm umbilical tape was pulled through one 
incision, under the artery and out through the other incision 
(Figure 15), 
The vessel was released and about 12 cm of umbilical tape 
was pushed into the incision. The ends of the tape were tied 
in a square knot (Figure 16). The long incision was closed 
with Vetafil^ using a simple interrupted pattern. The pro­
cedure was repeated on the opposite vessel. 
Fi.gure 13. Upper left„ Ischemia production procedure. Cloth wrap in place 
around neck to secure roll (arrow) over axis. 
Figure 14. Upper right. Ischemia production procedure. Pneumatic pressure 
cuff in place around neck and attached to pressure system. 
Figure 15. Lower left. Phase 2 surgery. Right side = anterior. Umbilical 
tape passed under common carotid artery and out second incision. 
Figure 16. Lower right. Phase 2 surgery. Right side = anterior. Common 
carotid artery has been released and bulk of tmibilical tape 
pushed into incision. Ends of tape are tied. 
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Brain ischemia production In Phase 2, brain ischemia 
was produced about six hours following recovery from the 
anesthesia of preparatory surgery. 
Immediately prior to brain ischemia production, both 
common carotid arteries were ligated with the umbilical tape 
which had been placed during Phase 2 surgery. The pneumatic 
cuff was placed around the neck and inflated within two 
minutes after the first artery was ligated. The rest of the 
procedure was as described for Phase I. 
VJhen the neck cuff was removed, the carotid ligatures 
were quickly cut with a scapel blade. The skin, which was 
within the ligature, protected the vessel from the blade. 
Determination of Serum Glutamate 
Decarboxylase Activity 
Three ml of blood were drawn from alternate jugular 
veins at the prescribed time and transferred to a 75 x 12 mm 
test tube. After cloccing, ic was centrifuged at about 
3000 rpm and the serum was transferred, sealed and refrig­
erated c Serum was usually refrigerated within 30 minutes of 
collection. Since the GDC determinations were done every 
morning, no sample was over 24 hours old when analyzed. 
The fluorometric method of analysis which Lowe et al. 
(1958) described was adopted for use, with certain modifica­
tions, in this study. The reagents were identical except 
that it was necessary to use a 1-6 N instead of a 0.4 M 
phosphate buffer. The 0.4 M solution was tested at the 
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recommendation of Robins^ and was found, as was a 0.8 H 
solution, to have a limited capacity to buffer serum to 
pH 6.8. The final buffer concentration in the reaction 
tube was 0.4 M instead of 0.1 H. The standards used were 
0.2 mM and 0.5 mîl gamma aminobutyric acid (GABA), All 
other reagent concentrations were used as recommended. 
Three hundred sixty narrow pass primary and 485 
c d 
mji sharp cut secondary filters were used in the fluorometer » 
The micro-technique5 which Lowe et al. (1958) used, was 
not used in the current study. Instead the volume of the 
reaction mixture was increased 150 times and of the ninhydrin 
and quenching mixture, lOO times. 
These particular increases in volume were selected be­
cause they yielded a final-volume of 5.3 ml which is ideal 
for the 75 x 12 mm cuvette used in the fluorometer. 
It was found that nearly every tube in a case of dis-
^ilobins; Eli. Department of Psychiatry and Neurology, 
Washington University School of Medicine, St. Louis, 
Missouri, Alteration of phosphatase buffer. Private 
communication. 1967. 
^Turner #110-811 filter. G. K. Turner Associates, 
Palo Alto, California, 
Turner #110-817 filter, G. K. Turner Associates, 
Palo Alto, California. 
"^Turner model 110 fluorometer, G, K. Turner Asso­
ciates, Palo Alto, California. 
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posable weight 75 x 12 mn culture test tubes^ could be used 
as a matched set of fluororaeter cuvettes at the Ix light 
intensity range. These tubes after having been chemically 
cleaned were screened in the fluororaeter at the 3Ox intensity 
range. Any tube which did not cause a needle deflection of 
more than 4 meter graduations on either side of zero was 
found to cause no deflection on the Ix range and was included 
in a matched set. 
This was very convenient as it enabled the use of the 
final reaction tube as the cuvette. This permitted running 
batches of five to seven serum samples and sample blanks in 
triplicate. 
The method used analyzed the product of the enzyme 
reaction, gamma aminobutyxic acid (GABA). To determine if 
the fluorometric reading was a linear function of GABA con­
centration, a standard curve^ which consisted of 11 points 
from 0.01 to 1.0 mM GABA. was constructed. Because the 
relationship was remarkably linear, the standard with the 
reading closest to that of the unknown sample was not used 
alone to calculate activity. Instead activities were cal­
culated with both standards and the mean of these two values 
was reported. The rationale was that any error due to lack 
of linearity would be more than compensated for by the ad~ 
^Academy© Pyrex© test tubes, disposable weight. 
Available from Aloe Scientific, St. Louis, Missouri. 
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vantage of doubling the number of data. 
The GDC activity was calculated and reported as p moles 
GA3A produced/hr/L of serum (international unit). ]'Jhen the 
term, unit, is used in further discussion, it will refer to 
the international unit as expressed above. 
Clinical Evaluation 
The animals were housed at the Veterinary Medical 
Research Institute (VMRI) at Iowa State University, Ames, 
Iowa. The facility consisted of an examination room and 
adjoining room in which the dogs were kept. 
For several days after shipment, manipulation of the 
animals was minimal so that they could become accustomed to 
the facility and the handlers. They were observed for 
alertness, disposition, appetite, gait and ease with which 
they jumped a 20 cm barricade between the examination room 
and the room in which they were kept. 
Prior to surgery, a hemogram consisting of total ery­
throcyte and leukocyte councs, leukocyte differential count, 
hematocrit and hemoglobin determinations was made. A 
neurological examination (KcGrath, 1960) was conducted in 
which the righting, placing, and pupil].ary reflexes, facial 
sensation and eye movement were evaluated. An ophthalmo­
scopic exai'ûination was also performed. 
From the time of surgery until the experiment was ter­
minated, clinical observations were made twice daily, and 
47 
neurological examinations were done at two day intervals» 
Another hemogram was made at three days post-surgery. 
Necropsy Procedure 
All experimental dogs of a particular block were 
necropsied nine days after ischemia was produced in Treatment 
1. They were anesthetized with Surital^ and killed by ex-
sanguination. The brain and spinal cord to the level of 
the sixth cervical vertebra were immediately removed intact 
from the cranial vault and vertebral canal. 
For tissue enzyme determinations, a five mm slice of 
cerebral cortex with underlying white matter was removed 
from the occipital and temporal lobes of each hemisphere. 
The cerebral cortex was separated from the white matter with 
a razor blade. Approximately one gram each of grey and white 
matter was diced and quickly frozen with freon^. It was 
wrapped in aluminum foil and kept frozen on dry ice. 
For histologic study, the remainder of the brain was 
immersed in 10% neutral formalin, A complete necropsy was 
conducted, and tissues with gross lesions were fixed in 
formalin. 
Kistochemical Procedure 
The fresh frozen brain sections were weighed; then they 
were homogenized with a Ten Broeck grinder in distilled-
a (^3 
Cryokwik ^  freon spray, International Equipment Co.. 
Needham Heights, Massachusetts, 
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deraineralized wacer. 'uaep. a homogenous suspension was 
attained, more water was added to achieve an approximate 
dilution of one gram of brain tissue per six ml of water. 
The exact dilution was later calculated. The grinding 
was done in an ice bath. 
The suspension was left for one hour at 4° C. It was 
centrifuged at 37,000 g for 30 minutes at the same tempera­
ture. The supernatant was stored in the refrigerator until 
analyzed. A further 10-fold dilution of the grey matter 
supernatant was necessary because of its high enzyme activ­
ity. The enzyme analyses were conducted within 24 hours. 
Histologic Procedure 
After fixationJ the remaining brain and spinal cord 
were cut in 5 mm transverse slices. These were embedded, 
cut and stained with hematoxylin and eosin as described by 
the Armed Forces Institute of Pathology (i960). Some 
sections were- stained with thionine for the elucidation of 
Nissl granules. 
Statistical Analysis 
The data generated from the serum enzyme determinations 
were statistically analyzed as a split plot. The treatment-
block combinations were the main-plots and the sample num­
bers (sampling times) comprised the sub-plots. 
The totals of the block by treatment interaction were 
analyzed first as a randomized block (RB), In the case of 
Phase 1 in which there were unequal treatment numbers in 
each cell, the X-matrix, which was used for the analysis, 
incorporated two covariants. The totals across treatments 
for each block were compared to determine if differences 
among blocks existed. 
Previous studies had indicated that it would be reason­
able to group the Phase 1 sample numbers into four time 
periods and Phase 2 into three periods. Table 3 indicates 
the division of these periods in Phase 1. In Phase 2, all 
samples (#15 - 24) taken after production of ischemia con­
stituted Period 3. 
Table 3. Division of Phase 1 sample numbers into time periods 
Sample 
Period numbers Basis for division 
J. V J .  - Baseline 
2 11 - 14 Immediate post-surgery period (0 - 42 
hours)o Period in which the values 
were rising rapidly. 
3 15 -  22 Plateauing period (42 - 180 hours post-
surgery. 
4 23 -  35 Post-ischemia period (0 - 216 hours 
post-ischemia or 186 - 396 hours 
post-surgery). 
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After the RB was analyzed, comparisons were made between 
Periods 1 vs 4, 1 vs 3 and 1 vs 2 across all treatments. 
Finally tests for linear trends (slopes) within Periods 
2, 3 and 4 were conducted. 
The data from the brain enzyme determinations were 
analyzed as a randomized block with sub-sampling. Since 
Phase 1 was an unbalanced experiment containing empty cells, 
it was analyzed by general linear regression. This was done 
to produce an analysis of variance that would be analogous 
to one produced by balanced data. 
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RESULTS 
Clinical Observations 
Phase 1^ 
post-sur%erv period i^iost of the 12 Treatment I and 
II dogs recovered from the effects of surgery in three to 
five days. They were depressed and not inclined to move 
their head and neck for two days post-surgery (P-S). They 
exhibited varying degrees of incoordination which were 
usually no more severe than slight weaving of the rear 
quarters or mild exaggeration of flexion when walking. By 
the fifth p-S day, these signs were usually imperceptible. 
Subtle incoordination could be detected beyond five days in 
an occasional dog as it jumped the barricade. Usually the 
righting reflex was mildly depressed up to seven days P-S. 
Two dogs were exceptions to the above observations. In 
the first of these, dog 222, a large piece of bone was broken 
loose during surgery compressing the spinal cord. After re­
covery from anesthesia, this animal appeared to be in great 
pain and had complete motor and sensory paralysis of all 
extremities. She was completely aware of her surroundings. 
Within 36 hours, there was extensor rigidity of the rear 
legs and adductor rigidity of forelegs. She was completely 
prostrate but could eat canned food from the table if placed 
near her mouth. In four days she was able to lie in near 
sternal recumbency. The spinal shock had passed but the left 
side was paralyzed. Viewed from above, the body and tail 
were slightly curved to the right. The dog could now move 
herself to left sternal recumbency. She would lie only on 
her left side; when put on the right side she would roll to 
the left side. Her condition remained the same until ischemia 
was produced. 
The second exception was dog 331. The surgery time was 
prolonged due to difficulty controlling hemorrhage. An 
estimated 25 to 35 ml of blood was lost. This animal did not 
make a normal recovery from surgery. While his reflexes were 
good, he remained depressed and slightly incoordinated, 
Seven and one half days after surgery (coincidently, 
the same time that brain ischemia was produced in Treatment 
I dogs) the animal had a convulsion while it was being bled. 
Consciousness returned after three to four minutes but the 
animal had lost locomotor function. Extensor rigidity of 
the limbs was present at 24 hours. In two days, very in-
coordinated walking was possible. The forefeet would not 
extend, however. Nine days after the convulsion (the day 
prior to necropsy), the dog could trot fast and juivip the 
barricade but was easily knocked down by his playful pen­
mates. He still had trouble extending the forefeet and was 
mildly ataxic. 
In dogs 241, 242 and 342 of Treatment III, subtle 
ataxia could be detected on the first F-S days by slight 
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wobbling of the rear quarters when landing from the barri­
cade jump. This had disappeared by the second day. Dog 341 
was depressed and reluctant to move for two days p-S, Ataxia 
continued through the third day. 
Treatment IV dogs (252, 351 and 352) appeared normal 
the day following anesthesia. 
During and after ischemia Of the eight animals which 
were subjected to the treatment (production of brain ischemia), 
three (dogs 221, 311 and 321) failed to lose the corneal and 
conjunctival reflexes and consciousness and did not stop 
breathing during the procedure. All were able to get up and 
walk within nine minutes after the pressure on the neck was 
released (post-treatment). The gait, in all cases, was ataxic. 
Ataxia had disappeared and all reflexes appeared normal with­
in two days post-treatment (P-T). 
The remaining five dogs became unconscious, lost the 
corneal reflex and stopped breathing d^jring the procedure = 
In three of these five dogs (222, 312 and 322), the latter 
effects developed slowly; consequently, the ischemic time 
was prolonged. 
Dog 322 developed a heart block during the procedure 
and died. Attempts to initiate the heart beat with external 
cardiac massage and intracardiac injection of epinephrine 
failed. The incomplete data from this dog were not used in 
in the statistical analysis. 
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In dogs 222 and 312, unassisted breathing was possible 
within two minutes and consciousness regained within five 
minutes after release of the pressure. Dog 312 was able 
to walk within 33 minutes and all abnormal signs refer­
able to the CNS had disappeared by 24 hours P-T. The re­
turn of locomotor function in dog 222, who was paraplegic 
prior to treatment, was difficult to assess. However, by 
five hours P-T, the latter animal was able to assume sternal 
recumbency and within 24 hours, her condition appeared 
similar to the pre-treatment condition. 
In the remaining two dogs (211 and 212), cessation of 
breathing and loss of consciousness and corneal reflexes 
occurred within six minutes of application of neck pressure. 
Dog 211 was able to breathe unassisted within two minutes 
and regained consciousness by three minutes P-T. This 
animal was able to walk in an incoordinated manner by 12 
hours P-T and showed no GN3 signs three days P-T. 
Signs of brain damage were most dramatic in dog 212. 
Artificial respiration was required for four minutes P-T 
and she was unconsciousness for more than 24 hours P-T. 
This dog Was unable to walk during the nine P-T days; but 
on the day prior to necropsy, some evidence of recovery 
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was noted by partial return of locomotor function. 
A typical response to the ischemia production procedure 
is illustrated by the following sequence of events for dog 
312. immediately after the pressure was applied, the neck 
extended and panting began (Figure 17). In 40 seconds, the 
animal fell on its side and began running movements 
(Figure 18). The lingual veins became blue-black and the 
tongue was purple (Figure 19) and cold. The intraocular 
pressure was markedly increased. In three minutes, there 
was extensor rigidity of the rear legs (Figure 20) and 
the pupils were dilated (Figure 21). The heart rate was 
120 per minute. At five minutes, extensor rigidity had 
extended to all legs and the mouth was tightly closed. 
The heart rate had increased to 210 per minute at 10 min­
utes. The rear leg rigidity had disappeared by 11 minutes. 
Breathing stopped at 14 minutes and artificial respiration 
was initiated at 15 minutes (Figure 22). At 17 minutes, 
the heart rate was 180 per minute and the rigidity of 
the forelegs had disappeared. The pressure was released 
at 19 minutes; 45 seconds later, extensor rigidity had 
returned to all four limbs (Figure 23). The tongue had 
returned to its normal color. Three minutes after pressure 
release the pupils were constricting. 
Figure 17. Upper left:. Immediately after 700 mm Hg pressure applied to 
pneumatic neck cuff. Neck extended and panting began. 
Figure 18. Upper rights Animal fell to its side and began running movements 
Figure 19. Lower left. Tongue color two minutes after application of the 
pressure in this animal which had a relatively slow response to 
the pressure. 
Figure 20. Lower right. Extensor rigidity of rear legs three minutes after 
application of pressure. 

Figure 21, Upper left:. Dilation of pupil three minutes after application of 
pressure, 
Figure 22. Upper right. Artificial respiration begun one minute after 
breathing ceased. Notice that all legs are relaxed. 
Figure 23, Lower left. Extensor rigidity of all four legs. Notice that the 
pressure has been removed. 
Figure 24. Lower right. Surgical anatomy demonstrated at post mortem. Notice 
the spinal cord (A), wing of atlas (B), collapsed vertebral artery 
(C), ligature on vertebral artery (D), and transverse process of 
axis (E), 
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Phase 2_ 
Post-surp.ery oeriod Since ischemia of Treatment I 
dogs was produced six hours following recovery from surgical 
anesthesia, no observations were recorded during this period. 
During and after ischemia The modified technique 
for the production of brain ischemia used in Phase 2 was 
very successful in producing signs of GNS damage. One ani­
mal in each of the two blocks died as a result of the pro­
cedure. 
Dog 411 began unassisted breathing nine minutes P-T 
but died 41 minutes later. Three minutes prior to death 
the heart was beating strongly at 150 per minute. Death 
apparently resulted from respiratory failure. 
Dog 412 was never able to breathe without aid, but life 
was maintained for 12 hours with respiratory assistance. 
Death occurred shortly after the endotracheal tube was 
removed. Because the data from the above two animals was 
incompleteJ they were not used in the statistical analysis. 
Animals 421 and 422 were maintained for the prescribed 
9.5 days of the P-T period. Their responses were quite 
similar. As each common carotid artery was ligated, there 
was a brief period of panting. When the neck cuff was in­
flated, each fell to its side immediately. Both dogs ceased 
breathing within 30 seconds and were unconscious and had no 
corneal reflex within 90 seconds. The sequence of events 
was very similar to that described for dog 312. but onset 
of each event was much faster. The heart rate reached 270 
per minute. Cerebral ischemia was maintained for eight 
minutes. During this time, the intraocular pressure did 
not increase in any of the Treatment I dogs. 
Dog 421 Was able to breathe unassisted nine minutes 
P-T and was unconscious for 30 hours. By three minutes P-T, 
422 was breathing voluntarily but did not regain conscious­
ness until 42 hours ?-T„ 
At 24 hours P-T^ 421 had to be fed by stomach tube. 
The pupils did not dilate in the dark. The limbs were 
flaccid and the feet cold. For 36 hours P-T, intermittent 
extensor rigidity was present. During the second day, the 
dog responded to auditory but not visual stimuli, seemed 
aware of his surroundings and finally was able to assume 
left sternal recumbency. By the fo^arth day he was able to 
eat food placed in front of him. The pupils still did not 
dilate normally. The dog still would not extend his legs 
when the toes were pinched. Eye movement was normal, 
vision had apparently returned, but righting and placing 
reflexes were negative. At seven days, the dog could slide 
around the pen. The appetite increased but signs referable 
to the CNS remained the same until he was necropsied 9.5 
days f-T. 
On the first and second days P-T, dog 422 developed 
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extensor rigidity of tha limbs and back when lifted. This 
was followed by paddling movements of the legs. He was 
apparently blind throughout the experiment. From the third 
day until termination, the dog was easily agitated by hand­
ling. Even chough he had a good appetite, attempts to force 
feed him resulted in spastic struggling movements. 
Dogs 431, 441; 451, 432 and 452 recovered from surgery 
in a manner similar to their counterparts in Phase 1 
(Treatments 11, III and IV). 
During surgery of dog 442, the dura mater over the 
dorsal part of the spinal cord was inadvertently ruptured 
and torn away. The next day he was paraplegic, had extensor 
rigidity of the limbs and back, and had to be fed with a 
stomach tube. On the second day, the rigidity was gone 
but the body was curved to the left. The legs, except 
the left rear5 became rigid when placed on the right side. 
This rigidity was absent when he was on the left side= The 
appetite was good and he had the ability to eat. On the 
fourth day J he was able to assume sternal recumbency un­
assisted, but muscle movement was spastic. The abnormal 
CNS signs continued until termination. 
Pathology 
The surgical wounds had healed without evidence of 
infection. The defect in the neck created by surgery was 
filled in with granulation ûissue by che cime Phase 1 dogs 
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termina'ced (16„5 days). The granulation tissue was dense, 
white5 firm and contained dense collagen. The seven day 
(dog 322) and 9.5 day (Phase 2 dogs) old defects were 
surrounded by some 4 mm of granulation tissue with centers 
containing greyish-brown, gelatinous fibrinous exudate. 
The vertebral arteries of all Treatment I and II dogs 
were found to be ligated (Figure 24). 
The only gross abnormalities found of the intact GN3 
were slight constriction of spinal cord at the level of 
axis and blood in epidural space on the floor of vertebral 
canal in dogs 322, 411 and 412. 
The type and extent of microscopic alterations of the 
spinal cord were generally related to experimental manipula­
tion of each treatment. Treatments II and III had similar 
histopathologic lesions. Therefore, these pathologic altera­
tions fell roughly in three classifications= In all cases, 
they were most pronounced in the area of the second cervi­
cal vertebra (G-2) and decreased in severity posteriorly to 
sixth cervical (G-6) where lesions were minimal or absent. 
Cephalad to G-2 or in G-1 spinal cord the microscopic 
lesions were minimal and primarily confined to Nucleus 
Gracilis and Nucleus Cuneatus, 
The most marked changes were found in Treatment I (com­
plete surgical procedure and application of instantaneous 
700 mm Hg pressure of the pneumatic cuff around the neck 
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over the axis) dogs. Hyalinization of few cytons (coagu­
lation necrosis) of Nuclei Gracilis and Guneatus and 
occasional demyelination of some nerve fibers, especially 
in the ventral funiculi; were found in G-1 cord. At G-2, 
there was often chronic focal pachymeningitis of dura mater. 
Demyelination with swollen and degenerated axones was found 
in lateral and ventral funiculi (Figures 25 and 26) and 
occasionally noted in dorsal funiculus. In some cases, there 
was marked poliomalacia and in a few cases poliomyelitis. 
Leukomalacia accompanied by marked demyelination occurred 
sporadically in lateral or dorsal funiculi. Gitter cells 
had infiltrated most malacic areas (Figure 27). The cerebro­
spinal canal was usually distended, frequently contained 
many gitter cells and was occasionally ruptured. 
Lesions of grey matter were usually not prominent in 
the G-3 cord. There were some hyalinized cytons and central 
chromatolysis. The demyelination was still prominent. The 
latter alteration was most prominent in the lateral and 
ventral funiculi in C-4 and at the G~5 level was practically 
indiscernible in the dorsal funiculi. Demyelination was 
present but not prominent in the ventral funiculi at C-6, 
almost absent laterally and was usually not seen in the 
dorsal funiculi. 
The above changes were applicable to most Treatment I 
dogs. Dogs 221, 311 and 321 in which ischemia production 
65 
had not been successful had much less severe lesions, how­
ever. There was some hyalinization of the cytons of the 
Nuclei Gracilis and Cuneatus„ There was scattered demyel-
inization in the lateral but more pronounced in ventral 
funiculi of the C-2 cord. This had diminished at C-4 and 
was absenz in C-6 levels. The Phase 1 dog (322) which died 
during treatment, had no discernible changes. 
The Phase 2, Treatment i animals which survived treat­
ment had severe lesions similar to those already described 
except leukomalacia of the dorsal funiculi was more pro­
nounced in Phase 2 (Figure 28), The dogs (411 and 412) 
which died during Treatment 1 and were necropsied immediate 
had severe lesions. Dog 411 had hemorrhage, disruption and 
disorganization of grey matter immediately surrounding the 
cerebrospinal canal and embracing most of dorsal horns of 
the grey matter and contiguous white matter. Massive 
destruction of spinal cord of dog 412 with much hemorrhage 
in the traumatized tissue and subarachnoid space was found. 
The next two distal segments of spinal cord had complete 
disruption of the dorsal funiculi with hemorrhage and rup­
ture of cerebrospinal canal. 
In the dogs which had the laminectomy but not the 
pressure of the pneumatic cuff (Treatments II and III), 
the changes were much less pronounced and very similar to 
those described for dogs 221% 311 and 321. In addition. 
Figure 25, Uoper left, ûerayelination with swollen and 
degenerated axones of the ventral funiculus 
of the spinal cord at the level of the axis. 
Phase 1,"Treatment Ï dog. The cerebrospinal 
canal (-0 and ventral sulcus (B) are visible» 
Hematoxylin and eosin stain, X 54. 
Figure 26. Upper right. Higher magnification of Figure 
25. Notice the large spaces surrounding the 
degenerated axones. Hematoxylin and eosin 
stain. % 210. 
Figure 27, Lower left. Gitter cell infiltration of a 
leuicomalacic area. Hematoxylin and eosin 
stain, X 2lO. 
Figure 28. lower right. Severe leulcomalacia and vessel 
dilation of the dorsal funiculus of the spinal 
cord at the level of the axis. The malacic 
area contains numerous gitter cells. Phase 2, 
Treatment I dog which survived treatment. 
The disrupted cerebrospinal canal is visible, 
Hematoxylin and eosin stain. X 54. 
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hyalinization of an occasional cyton and some leuko-
raalacia with glial cell infiltration were found at G-2 
cord levels. Dogs 231, 241 and 341 had no microscopic 
alterations. Exceptions to these observations were found 
in dogs 331 and 442 (Treatment II and III, respectively) 
which had atypical clinical courses following surgery 
previously described. The lesions in these two animals 
were severe and similar to those of Treatment I. 
The anesthesia control (Treatment IV) had some 
hyalinization of cytons in the Nuclei Gracilis and Cuneatus, 
There was occasional demyelination of few nerve fibers in 
the ventral and lateral funiculi throughout the cervical 
cord in dogs 252 and 451. 
f-Iany histopathologic alterations were found in the 
brain. Swollen neurons, shrunken dark staining cytons with 
perineuronal spaces, hyalinized neurons occasionally with 
Vacuolated cytoplasm and nerve cells with mild central 
chromatolysis were seen. Perivascular spaces were common. 
These findings were prominent in many large nuclei of brain 
stem, notably the red nuclei and substantia nigra. It must 
be emphasized that it is most difficult to differentiate 
some antemortem changes of nervous tissue from post mortem 
autolysis. 
While the impression was that these changes were slight 
ly more severe and numerous in Treatment I dogs tnan animals 
which received less experimental manipulation, such 
differences were indeed subtle and perhaps more apparent 
than real. 
HiId dilation of the lateral ventricles was noted in 
dogs 222, 311, 231 and 351, The latter dog was an anes­
thesia control. This alteration was more easily seen on 
the whole brain sections prepared for microscopic examina­
tion than at necropsy. No ventricle was larger than one 
cm in its greatest transverse dimension. The neurophil 
immediately adjacent to the ventricles appeared only very 
slightly compressed. 
Glutamate Decarboxylase Activity 
The results of the serum enzyme activities for Phase 1 
are given in Tables 4 through 7. Phase 2 data are presented 
in Table 8, The unit of activity is immoles of GAB A pro-
duced/hr/L of serum (international unit). 
The results of the brain enzyme determination for 
Phase 1 are given in Table 9 and for Phase 2 in Table 10. 
The activity unit used was mmoles of GABi\ produced/hr/lcg 
of dry brain tissue. 
The mean activity of the 290 baseline serum samples 
is 214 ^moles/hr/1, (units) with a standard deviation of 
the mean of 10 units. 
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Table 4. Treatment I - GDC 
Phase 1, serum 
iamoies/hr/L „ 
Block 
numbers L 
Dog 
numbers 211 221 212 999 311 321 312 322 
Sample 01 157 183 253 1^4 169 212 235 154 
02 124 120 220 303 151 166 143 133 
03 106 126 187 232 126 199 211 240 
04 140 120 137 205 119 174 178 228 
05 174 161 193 168 209 172 232 249 
06 125 155 213 147 178 189 284 158 
07 160 122 190 175 201 176 304 307 
03 183 183 293 221 191 133 175 221 
09 183 119 205 229 182 185 178 182 
10 194 124 202 246 227 253 250 281 
11 138 144 270 291 lis 87 140 151 
12 99 101 189 179 90 71 77 110 
13 105 160 302 244 230 149 176 176 
14 167 202 325 333 311 244 370 335 
15 208 216 423 366 220 218 370 344 
16 254 183 466 621 294 329 309 295 
17 234 240 309 317 376 352 223 217 
18 267 199 281 313 273 289 399 470 
19 236 217 325 307 372 296 327 302 
20 O O 0 352 335 333 280 299 198 279 
21 216 222 256 %4 273 369 271 283 
22 287 275 273 279 381 314 214 233 
23 212 288 300 286 252 194 M «m, m» 
24 248 300 305 246 339 295 215 — — — 
25 242 276 384 253 243 334 140 — 
26 248 278 432 321 377 353 294 — — — 
27 254 286 358 309 327 323 247 — — — 
23 242 297 300 252 175 236 350 — — — 
29 271 261 372 329 228 279 222 — — — 
30 191 233 299 277 328 299 299 — — — 
31 204 254 325 316 264 265 276 — — — 
32 180 270 201 269 241 284 291 — — — 
33 183 239 223 224 164 197 107 — — — 
34 184 209 353 288 248 245 210 — — — 
35 174 233 257 274 196 211 228 — - -
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Table 5. Treatment 11 - GDC accivic ies in lamoles /hr/L. 
Phase Ij serum 
B lock 
nuiTibers 1 2 3 4 
Dog 
numbers 231 232 331 332 
Sample Û1 loi 232 142 132 
02 168 286 183 112 
03 203 185 173 127 
04 145 195 145 
05 205 218 198 127 
06 179 193 199 155 
07 178 193 244 233 
08 156 200 201 123 
09 l4o 221 99 
10 190 290 202 204 
11 157 232 69 149 
12 134 235 78 105 
13 210 326 123 249 
14 260 367 217 382 
15 334 414 251 343 
16 275 c3ô 262 250 
17 309 361 326 276 
18 263 306 290 426 
19 314 326 353 305 
20 380 305 249 283 
21 221 230 339 250 
22 400 275 314 219 
23 323 258 348 310 
24 337 419 168 
25 312 278 390 133 
2 b 258 351 441 254 
27 451 258 3/1 266 
28 297 223 404 308 
29 285 3 06 294 271 
30 203 287 408 298 
31 271 356 359 280 
32 214 246 300 303 
33 227 250 184 210 
34 229 262 221 
35 256 343 321 264 
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Table ô. Treatment III - GDC activities in jjimoles/hr/L. 
phase I3 serum 
Block 
numbers L 
Dog 
numbers Î41 242 541 342 
Sample 01 
02 
03 
04 
05 
06 
07 
OS 
09 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
23 
29 
30 
31 
32 
33 
34 
35 
133 
134 
134 
151 
135 
133 
129 
151 
202 
136 
121 
139 
112 
252 
295 
231 
99 
241 
173 
261 
170 
242 
303 
196 
284 
232 
248 
226 
236 
l5b 
174 
200 
162 
224 
230 
279 
237 
306 
273 
196 
227 
195 
254 
264 
229 
9 o 
204 
188 
374 
567 
393 
303 
7 
299 
282 
zoo 
270 
261 
394 
253 
316 
321 
261 
354 
212 
231 
283 
289 
258 
241 
190 
219 
258 
162 
281 
244 
163 
214 
142 
128 
205 
210 
283 
292 
345 
409 
350 
2:)7 
327 
250 
259 
304 
278 
311 
248 
324 
184 
214 
267 
302 
213 
229 
297 
205 
266 
203 
246 
296 
279 
354 
236 
206 
318 
149 
152 
293 
345 
321 
258 
251 
469 
337 
293 
268 
232 
298 
184 
388 
241 
402 
471 
328 
372 
343 
502 
237 
330 
329 
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Table 7 « Treatment IV -- GDC activities in jamoles/hr/L, 
Phase Ij serum 
S lock 
numbers _2 2 3 
Dog 
numbers 252 351 352 
Sample Ol — — — 179 227 216 
02 — — 176 148 219 
03 — — — 165 157 236 
04 162 189 181 
05 — " — 184 180 305 
06 " — — 139 173 245 
07 179 207 274 
08 « « M 202 231 238 
09 " 250 140 192 
10 — — — 159 247 396 
11 mm M» 213 153 165 
12 •d w M 257 211 149 
13 303 222 267 
14 — — — 326 176 364 
15 392 171 251 
16 — — — 404 243 231 
17 mm mm mm 337 270 215 
13 M n M 3G1 210 453 
19 « U) M 331 328 243 
20 ^ — 284 209 256 
21 M W* MM 315 215 214 
22 * — 267 195 924 
23 •M «— mm 263 274 252 
24 mm imt mm 293 203 145 
25 — " — 241 252 251 
26 284 230 204 
27 M MK 1M> 209 - 267 292 
23 Ml M 268 223 292 
29 mm mm .m 258 226 312 
30 M W» •» 211 253 282 
31 mm m» imm 293 179 338 
32 «M w3 ua 191 187 514 
33 «m* «*» 212 152 209 
34 *• w 236 219 419 
35 M 265 243 344 
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Table 8, GDC activities in jjimoles/hr/L. Phase 2, serum 
Treatment 
number I II III IV_ 
3 lock 
number I 2 12 12 1 ^ 
Animal 
number 411 421 412 422 431 432 441 442 451 452 
Sample 
01 206 241 174 170 271 216 237 159 280 226 
02 204 195 237 196 245 201 187 160 258 241 
03 124 211 2S8 225 193 325 163 249 238 244 
04 119 237 279 166 205 418 249 214 168 450 
05 155 292 279 201 200 322 171 221 173 417 
06 169 247 200 163 245 325 284 236 240 308 
07 235 222 275 197 510 312 262 250 253 322 
08 192 236 274 227 238 402 228 265 209 411 
09 170 212 253 321 246 329 228 394 226 436 
10 186 267 243 207 243 286 280 336 265 307 
II 167 126 164 214 317 • 174 249 243 341 
12 222 242 236 188 430 89 420 124 481 
13 — — — 274 — — — 272 192 364 201 291 234 294 
14 — — — 367 — 340 286 289 297 285 198 292 
15 MS M MB 397 mm -m» m» 351 357 449 345 353 320 468 
16 — — — 328 — — — 286 295 386 267 354 212 420 
17 — — 285 » M 226 349 294 247 319 369 322 
18 — — 460 — — — 292 354 325 361 323 252 237 
19 — — — 322 — — — 471 387 410 285 478 446 427 
20 «» » «• 888 311 508 317 377 384 431 342 
21 539 — — — 329 384 236 335 431 344 240 
22 — — — 434 567 380 385 311 392 357 362 
23 — 468 — — 456 385 266 423 348 391 326 
24 — — = 324 347 238 242 244 221 282 334 
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Table 9. Brain GDC activity in iruaoles/hr/kg dry tissue. 
Phase 1 
Grey matter Villi te matter 
Treat- Dog Left Right Left Right 
ment Block no. side side side side 
-
211 
221 
48.9 
45.4 
48.8 
46.8 
21.6 
21.1 
12.1 
18.6 
2 212 
222 
14.6 
9.0 
7.1 
23.8 
3.9 
3.8 
8.8 
3.9 
3 311 
321 
30.7 
30.7 
36.1 
39.8 
4.7 
6.7 
7.5 
6.4 
4 312 
322 
41.4 41.4 3.2 0.2 
1 231 39.1 40.7 16.9 17.5 
2 232 13.9 14.5 4.9 8.8 
3 331 36.7 29.2 5.5 5.6 
4 332 51.4 52.7 1.6 7a 
1 241 51 o i 43 e 0 15.3 20.1 
2 242 41.9 51.6 8.9 8.2 
3 341 44.9 56o6 5.8 10.6 
4 342 42.9 39.4 5.7 5.4 
1 
2 252 50.9 44.6 10.2 10.8 
3 351 44.2 42.3 7.0 16.7 
4 352 39.7 39.8 9.4 9.1 
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Table lO. Brain GDC activity in minoles/hr/lcg dry tissue 
Phase 2 
IreaL-
ment Block 
Dog 
no, 
Grey matter 
Left Kighl 
side side 
I-Jhite matter 
Left Right 
side side 
1 
2 
421 
422 
3^ L.O 
34.9 
40.4 
36.9 
4.6 
3.9 
4.2 
6,5 
II 431 
432 
30.8 
41.9 
31.9 
45.4 
7.2 
5.8 
4.5 
6.7 
III 1 
2 
441 
442 
31.9 
34.0 
39.9 
25.9 
IJ 
1.4 
9.9 
2.1 
IV 451 
452 
36.5 
33.3 
27.7 
29.9 
5.9 
3.2 
4.3 
6.0 
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DISCUSSION 
The Method and Design 
The method of Dennis and Kabat (1939) appeared to be 
the logical choice for the production of complete cerebral 
anoxia. Its selection was based on the facts that (1) it 
produced occlusion of the major arteries supplying the brain 
cranial to their anastamotic connections with other vessels 
and (2) it occluded the ventral spinal artery. The method 
consistently produced signs of CMS disturbance (Dennis and 
Kabat, 1939; Grenell, 1946; Kabat, 1940; Kabat and Dennis, 
1938; Kabat et al., 1941). 
The age resistance of young animals to brain anoxia 
was an important factor in seleccing the dogs. Kabat (1940) 
found that dogs four months and older were similarly suscept­
ible to its effects. So that age would not be an appreciable 
Variable in this study, the experiment was restricted to 
animals five and six months old. 
The design of the experiment was influenced largely 
by the time required to conduct the surgery and the enzyme 
analyses. Relatively few animals could be started at "one 
time". This introduced the chance that subtle changes in 
the procedure such as improvement of surgical technique and/ 
or Variations in new batches of chemical reagents might 
cause some variation in the results. Blocking of the experi­
ment was instituted as it provided a means of isolating such 
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Variation in an analysis of variance. 
Since GDC in serum had not previously been studied, 
the factors which might influence its "normal" serum levels 
were not known. Therefore, it was decided to make sure that 
the baseline did not change after surgery. To do this, 
brain ischemia production procedure was conducted 7.5 days 
after surgery (Phase 1). During this interval, serum GDG 
levels were to be determined. 
A preliminary study was conducted which consisted of 
four Treatment I (brain ischemia 7.5 days after surgery) 
and two Treatment II (surgery control) dogs. From the 
results of this study^ it not only appeared that serum GDG 
activity did increase but also that the post-surgery (p-S) 
period was as important as the post-treatment (P-T) period. 
It seemed logical that the vertebral artery ligation could 
be causing enough hypoxia with resultant GNS damage to cause 
an increased serum GDC activity. To test this idea, a 
laminectomy control^ in which vertebral arteries were not 
ligated, had to be added (Treatment III). 
The data from the preliminary study were examined, and 
the method of analyzing it from the final experiment was 
determined. They indicated that it would be reasonable to 
divide the samples into four time periods. The basis of the 
division was the apparent similarity of values or tendency 
of Values to be increasing or decreasing within the period 
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(Table 3). This tecimique decreased the number of sub­
plots from 35 (sampling times) to four (time periods) but 
increased the number of samples within sub-plots (hence 
degrees of freedom) from one to as many as 13 (period 4). 
These preliminary data were not used in the statistical 
analysis of the final experiment. 
The later emphasis placed on the p-S period necessitated 
a P-S sampling schedule as intensive as was used in the P-T 
period. The number of baseline samples was increased from 
four to 10 because of the wide variation in baseline values 
within individual dogs noted in preliminary study. The 
final sampling schedule was given in Table 2. 
As Block 1 was being conducted, the results of the 
enzyme determinations were being examined. Since no ob­
vious difference appeared among the treatments, it seemed 
doubtful that the experiment was being controlled adequate­
ly enough. 
The next logical step in controlling tne experiment 
was the elimination of the laminectomy from the procedure. 
It could have included muscle trauma but GDC has not been 
found outside the GNS. It was desired to use a control which 
would cause little or no elevation of GDC activity. Because 
only one more animal could feasibly be added to a block, 
it was decided to use an anesthesia control. 
Block 1 data were useable even though they unbalanced 
the experiment. 
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Pathology and Clinical Response 
The microscopic examinations of the cervical spinal 
cord revealed that, in this study, the process of removing 
the spinous process and roof of the vertebral canal resulted 
in appreciable lesions of the cord. This probably accounts 
for the P-S incoordination seen although the theory, derived 
before the cords were examined, that the vertebral artery 
ligation caused brain damage, cannot be discounted with 
certainty. 
There was some direct correlation between the severity 
of the microscopic cord lesions and the clinical response 
of Phase 1, Treatment I dogs to treatment. Dogs 211 and 
212 which had a clinical response indicative of complete 
cessation of blood flow to the brain during treatment and 
dogs 222 and 312 whose response was indicative of near com­
plete ischemia had severe lesions of the spinal cord 
especially at C-2. Dogs 221, 511 and 321 in which clinical 
signs of ischemia did not develop, likewise, had cord 
alterations similar to those of animals on which surgery 
but not treatment had been performed. Also, severe cord 
damage was found in Phase 2, Treatment i dogs which had an 
excellent clinical response to treatment. 
The less than optimum clinical response of Phase 1, 
Treatment I animals to the brain ischemia procedure, was 
not entirely unexpected= In their original report, Kabat 
Si 
and Dennis (1938) had produced cerebral ischemia one to two 
weeks after preparatory surgery. This interval was later 
decreased to two days (Dennis and Kabat^ 1939). The reason 
was not given but Grenell, who used the same technique^ 
stated that; 
The experiment must be performed soon after the 
laminectomy, since complete arrest of the circula­
tion is no longer possible if the procedure is 
delayed for more than a week, by reason of the 
development of a heavy scar over the laminectomy, 
which protects the spinal vessels from external 
pressure. 
Since granulation tissue formation was well developed 
at seven and nine days P-S, it appeared that, in this 
study, the healed lesion protected the spinal cord from 
further damage, and, in some cases, the ventral spinal 
artery from compression and presumably the brain from damage 
caused by ischemia. 
Histopathologic lesions of the brain were not pro­
nounced, Changes appeared in the cerebral cortex but 
differences between treatments, if present, were so subtle 
that an objective evaluation with definite conclusions could 
not be made. Killing the dogs by perfusion of the brain with 
formalin would have helped determine if these changes had 
occurred before or after death. Such information would 
probably have been of greater value than the brain enzyme 
studies which were conducted at the expense of good fixation. 
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Grenell (1946) but glial infiltration and neuronophagia 
ware not found. The studies of Lucas and Strangeways 
(1963 b) which indicated that cortical changes were most 
prominent five days after treatment (anoxia), were diminish 
ing at nine days and were, much less obvious after 14 days, 
lend credence to the idea that the animals in this study 
were not killed at the optimum time for the sensitive 
detection of lesions, 
Metz (1949) was not able to see much histologic nerve 
damage in the brain after subjecting several species to 
severe grades of hypoxia. He emphasized the possibility 
that the changes which may have occurred were not morpho­
logic in nature but rather were biochemical phenomena at 
a submicroscopic level. 
vfnen considering the interval for Phase Ij between 
surgery and treatment, it was anticipated that histopatho­
logic criteria could be used to evaluate the degree of 
brain damage. Since, under the conditions of this experi­
ment, histopathology appeared to be of little value, clini­
cal response to ischemia became the parameter of choice to 
evaluate the degree of brain damage production. 
The presence of severe cervical cord lesions in the 
dogs that developed pronounced CNS signs as a result of 
the ischemia production procedure introduced the question 
as to whether the signs were the result of brain or spinal 
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cord damage. 
Gotnaionly known responses to the sectioning of various 
levels of the brain and spinal cord found in standard 
physiology texts (e.g., Guyton, 1966) would indicate that 
extensor rigidity noted in this study could only be caused 
by brain damage. The occasional lack of pupillary response 
to light or darkness, blindness, the loss of consciousness 
and the lack of awareness of the surroundings found in 
phase 2, Treatment I dogs also seem to be brain-specific 
signs. 
The placing and righting reflexes require an intact 
spinal cord. In the presence of cord lesions, loss of these 
reflexes would be difficult to interpret. Likewise, Che 
cause of respiratory depression, when both brain and cord 
lesions are known to exist, would be hard to assess. 
Anoxia will produce respiratory depression (Drinker, 1938) 
and cleavage of Che spinal cord at the level of C-2 will 
result in respiratory failure. Such severe signs of respira 
tory failure occurred in only two dogs. The remainder of 
Treatment I had to have had at least some functional tracts 
left. 
The extensor rigidity appears to be unequivocal evi­
dence that brain damage occurred, at least in Phase 2, as 
a result of treatment and that the cord was not effectively 
sectioned. 
The short terra paraplegia in the dogs which had a-
typical clinical courses P-3 (222 and 442) would seem to 
be similar to the "spinal shock" of a sectioned cord 
(Guyton, i960). The extensor rigidity which followed was 
not typical of the signs of a sectioned cord and would have 
to be explained on the basis of interruption of inhibitory 
impulses from higher centers caused by some brain damage. 
Glutamate Decarboxylase 
Brain 
The data from the brain GDC activity were analyzed 
as a randomized block (R3) with sub-sampling. The sub-
samples were the individual data from each side of the 
brain. Separate analyses were conducted for the grey and 
white matter of each phase. 
In the grey matter of Phase 1, the block and treatment 
effects were not significant even though the Treatments I 
and II means appeared lower than those of Treatments III 
and IV. There appeared to be a high degree of block by 
treatment interaction. 
The block and treatment effects of the Phase 1 white 
matter were significant. As with the grey matter, the 
treatment difference appeared to be between Treatments II 
and III, Treatments I and II were lower than III and IV. 
The block difference appeared to be caused by very high 
(2-fold) Values in Block 1 compared to Blocks 2, 3 and 4. 
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The block by treatmenc interaction was minimal» 
The grey and white matter data of Phase 2 were neither 
different between blocks or treatments. The block by treat­
ment interaction appeared to be high. 
In all cases, the sampling sums of squares was low 
indicating that the difference between left and right 
halves of the brain was low. 
The results of the grey matter determinations indicated 
that the procedure used in this study was capable of giving 
results comparable to those of other investigators. The 
mean grey matter GDC activity of Phase 1, Treatment IV dogs, 
which should have been least affected by treatment, was 78% 
of the mean activity for monkeys found by Lowe et al. (1958). 
Detectable activity was found in the white matter, 
however. The mean white matter activity of all dogs in 
Phase 1 was 9.3 and in Phase 2 was 5.2 mmoles/hr/kg dry 
brain. 
The experiment was not designed to study the response 
of the brain and only grey matter treatment differences 
could have been interpreted. Therefore, no conclusions 
are made based upon the results of the brain tissue deter­
minations . 
Serum 
Phase I Based upon examination of the data from 
the preliminary studies it was decided to analyse the data 
generated from the experiment as a split-plot. The treat-
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ment-block combinations were the main-plots and the sample 
numbers (sampling times) comprised the sub-plot. In Table 
4, there are four treatment-biociv combinations (main-plots) 
and 35 sample numbers (sub-plots) in each. 
The totals of block by treatment interaction were 
analyzed first as a randomized block (R3) with unequal treat­
ment numbers in the cells (Block 1 did not contain Treatment 
4, anesthesia control). To do this an X-matrix was con­
structed incorporating three degrees of freedom (d.f.) for 
blocks, three d.f. for treatments and nine d.f, for the 
block by treatment interaction. In fact, these nine d.f. 
were not entirely block by treatment because one such cell 
was empty (Treatment IV, Block l) and several contained 
two dogs (Treatment I, Blocks 1, 2 and 3). To cope with 
this, two covariants were incorporated using values of -1 
for the empty cell and zero elsewhere (Goons, 1957). In 
the empty cells, zero was used as data. 
Because all cells of the RB did not contain the same 
number of dogs, to say that "totals" of blocks by treat­
ment interaction were analyzed is not strictly correct. It 
would be more accurate, though more cumbersome, to say that 
the weighted means of all of the data in each cell of the 
RB were analyzed for block by treatment interaction. Hav­
ing made this distinction, however, the use of the term 
"totals" will be continued. 
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In this initial part of the analysis (Table 11, 
Lines 1, 2 and 3) the "totals" across treatments for each 
block were compared to determine if differences among 
blocks existed. As indicated in the "F" column (Table 11, 
Line l), the block effects were not significant, i.e., 
there were no differences among blocks. Because the data used 
in this part of the analysis were "totals" across all samples 
for each dog, the treatment effects were also not signifi­
cant (Table 11, Line 2)o This point is also illustrated by 
examination of the sum of the means for each treatment 
across all time periods (Table 12, right hand column). It 
is evident tliat these values were not different. 
Error "a" (Table 11, Line 3) was the block by treatment 
error of the RB and tests for block effects. The magnitude 
of the block by treatment mean square (error a) compared 
to the mean square for treatment suggested that there was 
some block by treatment interaction. The R3, in addition 
to testing for block effects, isolated some of the varia­
tion in the data and made the rest of the analysis more 
sensitive. 
After the RB was analyzed, comparisons were made 
between Periods 1 vs 4, 1 vs 3 and 1 vs 2 (Table 11, Lines 
4, 5 and 6). These non-orthogonal comparisons accounted 
for all the degrees of freedom. Periods 1 and 4 as well 
as 1 and 3 were very highly significant for differences 
while there was none between Periods 1 and 2. This analysis 
Table 11. Analysis of variance. Phase 1, serum 
Degrees of 
Line Source freedom Sums of squares Mean Square F 
1 Blocks 3 357,644 119,215 2.43 ns 
2 Treatments 3 34,850 11,617 <1 ns 
3 Error (a) 9 439,987 48,887 
4 Period 1 vs 4 (r) 1 580,797 580,797 201.6 6':""* 
5 Period 1 vs 3 (s) 1 813,254 813,254 284 .  35*:'-':  
6 Period 1 vs 2 (t) 1 2,932 2,932 1.03 ns 
7 Linear in 2 (u) 1 202,223 202,223 70.7 1**:'( 
8 Linear in 3 (v) 1 92,057 92,057 32.  19:'"'"':  
9 Linear in 4 (w) 1 31,010 31,010 10 . 84*:'-': 
10 Treatments x (r) 3 120,108 40,036 14.00"** 
11 Treatments x (s) 3 175,077 58,359 20.41*** 
12 Treatments x (t) 3 10,603 3,534 1.24 ns 
13 Treatments x (u) 3 22,350 7,450 2.60* 
14 Treatments x (v) 3 8,638 2,879 1.01 ns 
15 Treatments x (w) 3 45,124 15,041 5.25** 
16 Error (b) 590 1,687,424 2,860 
= not significant; = .05; ** = .01; *** = .001. 
Table 12. Table of means (Treatment vs Period). Activity in nmoles/hr/L. 
Phase 1, seri-im 
Period Sum of means 
across 
Treatment 1 2 3 4 periods 
I 185^ (185)^ 195 (190) 299 (290) 264 943 
11 185 (185) 195 (206) 299 (315) 290 969 
111 212 203 296 277 987 
IV 206 234 274 257 970 
Sum of means 
across treat-
ments 788 827 1167 1087 
^Identical means for Treatments I and II in Periods 1 through 3 are given 
since the experimental ma,nipulation of these dogs was identical in those periods. 
^Data in parentheses are the separate means of Treatments I and II for 
Periods 1 through 3. 
These footnotes also apply to Table 13. 
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showed that Periods 3 and 4 were very different from the 
baseline period. These differences are demonstrated by 
examination of the sum of the means for each time period 
across all treatments (Table 12, bottom row). They are 
illustrated graphically in Figure 29 where the means for 
each sample number (time) of all Phase 1 dogs were plotted 
against time. This analysis compared the "totals" across 
all treatments within a given time period and, therefore, 
did not give any indication of a difference due to 
treatment. 
The next part of the analysis (Table 11, Lines 7, 8 
and 9) was a test for linear trends within Periods 2, 3 
and 4. It was assumed that Period I would not show a trend 
as it was the baseline period. Each of these periods was 
very highly significant for trend, i.e., the values within 
each period are indeed increasing or decreasing in a linear 
fashion as they appear to be (Figure 29). As above, no 
inference can be made as to whether these trends were 
caused by one of more of the treatments. 
Essentially it was the interaction of the 1 vs 3 and 
1 vs 4 comparisons as well as the interaction of trends 
with treatments which were of primary interest. This would 
indicate whether the effects were different from treatment 
to treatment. Tests were conducted on the interaction of 
treatment effects with (I) the time period differences 
Figure 29a. Overlay of Figur-e 29b. Illustrates the time period divisions 
and regression lines for each period. 
Figure 29b, Mean plot. All dogs. Phase 1, serum. 
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(Table 11, Lines 10, 11 and 12) as well as (2) the linear 
trends (Table 11, Lines 13, 14 and 15). Respectively, it 
was found (1) that there were very highly significant 
treatment effects on the 1 vs 4 and 1 vs 3 time period 
comparisons (Table 11, Lines 10 and 11, column "F"), 
(2) that the treatment effect on the trends in period 2 
was significant, and in period 4 was highly significant. 
(Table 11, lines 13 and 15, column "F"), ITiis, however, 
did not indicate which treatment caused these differences. 
Thus, at this point, it was known that there were 
differences in the level of enzyme activity among some of 
the time periods of the experiment, that linear trends did 
exist, and that these differences and trends were due to 
some treatments applied. It remained to be determined if 
these treatment effects were congruous with the idea that 
the increased levels should have occurred in the animals 
in which brain damage was produced. 
Unfortunately there was no valid way of statistically 
comparing these treatments two at a time (i.e., I vs II, 
II vs IV, etc.). Hence subjective analysis had to be 
attempted, 
To judge which treatments were causing the differences 
between Period I and 4 as well as 1 and 3, a table of means 
was constructed (Table 12), each cell of which contained th 
unweighted means of all serum GDC levels of all the animals 
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for a particular treatment-period combination. Table 13 
was constructed to enable comparisons, for each treatment^ 
of the means of Periods 3 and 4 with Period 1. The treat­
ment effects could then be evaluated by finding the differ­
ences between treatments for each period comparison (1 vs 
3 and 1 vs 4). These treatment differences are also given 
in Table 13» 
It will be recalled from the design of the experiment 
that dogs in Treatments I and II were handled identically 
through Period 3, i.e., these treatments varied only in that 
Treatment I and not Treatment II dogs were subjected to 
acute brain ischemia 7.5 days following surgery. Therefore, 
the means of all 11 dogs of Treatments I and II through 
Period 3 are given in Tables 12 and 13, The separate means 
of these two treatments are placed in parentheses. 
In the 1 vs 3 comparison, the differences between the 
two periods for Treatments I-II, III and IV were 114, 84 
and 68 units, respectively (Table 13). Since the analysis 
indicated that a difference did exist somewhere among 
treatments, certainly the I-II vs IV difference of 46 units 
was significant, i.e., the surgery which involved ligating 
the vertebral arteries and the laminectomy caused signifi­
cantly greater GDC elevation than anesthesia alone. 
The conclusion that anesthesia (Treatment IV) alone 
did cause some elevation of the serum enzyme activity is 
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Table 13. Period comparisons and treatment differences. 
Activity in jamoIes/hr/Lc Phase 1, serum 
Periods compared 
1 vs 3 1 vs 4 
Treat­
ment 
Period 3 
minus 
Period 1 
Treatment 
differences 
Period 4 
minus 
Period 1 
Treatment 
differences 
I (105) 79 
H
 
M
 1 l
-
l 
114 I vs II = 26 
II (130) I-II vs III = 30 
I-II vs IV = 46 
105 
-
III 84 
III vs IV = 14 
65 II vs IV = 54 
III vs IV = 14 
IV 68 51 
probably inescapable as the 68 unit rise in Period 3 over 
the baseline was a 33% increase, and it was a greater 
difference than found among any of the treatments. However, 
it must be remembered that the data in Table 12 were un­
weighted means from raw data and such a conclusion is based 
on subjective rather than statistical evaluation of the data. 
Whether the 84 unit elevation in Treatment III (Table 
13) is different from Treatment I-II and/or IV is more 
difficult to determine. Since III is 30 units lower than 
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I-II and 16 units higher than IV and because it must be 
different from either or both I-ll and IV, it is most 
probably at least different from I-Il, i.e., 1=II>I1I^IV, 
However, since the chronological progression of the treat­
ment numbers was inverse to the potentiality of the treat­
ments to produce brain damage, the strong inference is 
that the difference between each treatment was significant 
and that there was a trend across treatments, i.e., 
I=I1>III>1V. 
Subjective analysis of the 1 vs 4 comparison was more 
complex because (1) the experimental manipulation of 
Treatments I and II was different at the onset of Period 4, 
hence differences between these treatments could have been 
significant, and (2) the 1 vs 4 differences were unexpected­
ly higher in II (105 units) than in I (79 units) (Table 13), 
It would appear that a significant treatment differ­
ence might exist between I and II since the difference of 
26 units between them is higher than the 14 unit differences 
between I and III and between III and IV. However, examina-
tion of the separate means of Treatments I and II in the 
1 vs 3 comparisons (Table 12, values in parentheses) reveals 
that a 25 unit difference actually occurred between these 
treatments in Period 3 and strongly suggests that the 26 
unit difference found in the 1 vs 4 comparison is merely 
a reflection of the I vs II difference of Period 3. Since 
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this difference between I and II could not have been caused 
by a treatment difference in Period 3, it seems likely that 
it also was not in Period 4. 
It is likely that each treatment mean in Period 4 was 
a reflection of its counterpart in Period 3„ lh.is is shown 
by the fact that the decrease in activity from Period 3 to 
4 is very similar for each treatment, i.e., the Period 3 
minus the Period 4 mean for each treatment (Table 12) was 
between 17 and 26 units. Therefore, the interpretation for 
the 1 vs 4 comparison would be similar to that of the 1 vs 
3, i.e., I=II>III>IV. 
To help determine which of the treatments caused the 
significant trend by treatment interaction in Periods 2 and 
4, the slopes of lines for each treatment by period combina­
tion were determined by calculating the regression coeffi­
cient (b) for each line (Table 14), To visualize the re­
sults, the sample means for treatments I, II, III and IV 
have been plotted (Figures 30. 31, 32 and 33, respectively). 
The overlay with each of these plots demonstrates the slope 
of the line for each period. 
In Period 2 (Table 14), the increase in serum GDC 
levels is most rapid in treatments I and II (b = +0,537), 
less so in treatment III (b - +0.508) and far less rapid in 
treatment IV (b = +0.418). The impression is gained that 
since a treatment induced difference does exist (Table 11, 
Table 14. Regression coefficients (b) for treatments within periods. 
Phase 1, serum 
Treatment 
Period 2 
+0.511* 
Regression coefficient 
Period 3 
-0.043* 
Period 4 
-0.021% 
I (+0.486)b (-0.018) -0.038 
I  and II +0.537 -0.036 
11 (+0.629) (-0.052) -0.012 
III +0.508 -0.058 -0.010 
IV +0.418 +0.007 +0.018 
^Regression coefficient for 
^Values in parentheses are 
II for Periods 2 and 3. 
all dogs. 
the separate coefficients of Treatments I and 
Figure 30a. Overlay of Figure 30b. Illustrates the time period divisions and 
regression lines for each period. 
Figure 30b. Mean plot. Treatment I dogs. Phase 1, serum. 
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Figure 31a. Overlay of Figure 31b. Illustrates the time period divisions and 
regression lines for each period. 
Figure 3lb„ Mean plot. Treatment II dogs. Phase 1, serum. 
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regression lines for each period. 
Figure 32b. Mean plot. Treatment III dogs. Phase 1, serum. 
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Figure 33b. Mean plot. Treatment IV dogs. Phase 1, serum. 
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Line 13), it is between Treatments III and IV, i,e., 
I=II=III^IV. 
In Period-4, a surprisingly negative slope is found in 
Treatment I which is steeper than in any of the other treat­
ments. Examination of the regression coefficients in Table 
14 leads one to suspect that two treatment differences exist, 
i.e.; Ij^II=IIl5^IV. However, since the animals of Treatment 
I were the only ones to receive experimental manipulation at 
the onset of Period 4, it is tempting to suggest that 1^11= 
III=IV. It seems more likely, however, that, as previously 
suggested, the Period 4 enzyme patterns were a reflection of 
those of Period 3 and the actual slope difference is between 
Treatments III and IV, i.e., I=II=III^IV. 
The final error of the analysis of variance (ANOV), 
error "b" (Table 11, Line 16) was obtained as a combination 
of all other effects. It includes and isolates from the 
rest of the analysis interactions among blocks and sub­
plot (sampling times) effects, departures from linearity, 
experimental error, sampling error, and other sources of 
variation not isolated in the first 15 lines of Table 11. 
It is a true residual and could conceivably be inflated 
by effects not isolate, however, it it believed to be a 
good error term. 
Phase 1 The Phase 2 data were analyzed (Table 15) 
in the same manner as Phase 1. Because the Phase 2 analysis 
Table 15, Analysis of variance. Phase 2, serum 
Degrees of 
Line Source freedom Sums of squares Mean squares F 
L Blocks 1 40,176 40,176 1. 12 ns' 
2 Treatments 3 22,408 7,469 <1 ns 
3 Error 3 103,690 34,563 
4 Times 23 813,987 35,491 
5 (a) Period 1 vs 2 1 3,443 3,443 <1 ns 
6 (b) Period 1 vs 3 1 447,322 44,732 64. 18^' 
7 (c) Linear in 2 1 11,771 11,771 1. 79 ns 
8 (d) Linear in 3 1 161 161 <1 ns 
9 Residual times 19 310,774 16,357 
10 Treatments x times 69 306,433 4,441 
11 Treatments x (a) 3 5,584 1,861 <1 ns 
12 Treatments x (b) 3 85,240 28,413 4. 33^ 'rïV 
13 Treatments x (c) 3 37,208 12,403 1. 89 ns 
14 Treatments x (d) 3 46,008 15,336 2, 33 ns 
15 Residual interaction 57 135,371 2,375 
16 Error 92 603,308 6,558 
17 Total 191 1,890,004 
^Level of probability: ns = not significant ; ** = . 01; *** = = .001. 
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was balanced5 partitioning of the sums of squares for times 
and treatment x times interaction was possible. This per» 
mitted the isolation of residual sums of squares from each 
partition which in turn made the analysis more sensitive. 
As with Phase 1, the analysis of variance first tested 
for block and treatment effects (Table 15, Lines 1, 2 and 
3). The findings and interpretations are the same as given 
for Phase 1. 
There was no Period 4 in Phase 2. The 1 vs 3 compari­
son was very highly significant for difference (Table 15, 
Line 6). There was not, however, any significant trend in 
either Period 2 or 3 (Table 14, Lines 7 and 8). These facts 
are illustrated in Figure 34 in which the means for each 
sample number (time) of all Phase 2 dogs are plotted against 
time. The Period 3 GDC activity is seen to be elevated but 
the regression lines of Periods 2 and 3 are not steep, and 
in Period 3^ are probably not linear. Note that the X and 
Y axes of the Phase 2 plots (Figures 34 through 38) have 
different activity and time scales than was used on the 
Phase 1 plots. 
The test for treatment effects was significant for the 
1 vs 3 comparison. As in Phase 1, a table of means was 
constructed (Table 16) and the periods compared (Table 17). 
Table 17 is much easier to interpret than its Phase 1 
counterpart. The difference between Periods 1 and 3 means 
I t 
Figure 34a. Overlay of Figure 34b. Illustrates the time period divisions and 
regression lines for each period. 
Figure 34b, Mean plot. All dogs. Phase 2, serum. 
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Table 16, Table of means (Treatment vs Period). Activity 
in lamoles/hr/L. Phase 2, serum 
Period Sum of means 
across 
Treatment 12 3 periods 
1 222 258 404 884 
II 277 284 347 908 
III 238 251 340 829 
IV 284 276 344 904 
Sum of means 
across treat­
ments 1021 1069 1435 
in Treatment I is 182 units. This is 80 units (78%) higher 
than the next lower difference (Treatment III). There is 
little doubt that the Treatment I elevation of serum GDC 
activity is actually higher than in any of the three 
controls. This can be seen by comparing Figure 35b wii-li 
Figures 36b; 37b and 38b. 
Whether other differences exist is difficult to deter­
mine since they were about the same among the remaining 
treatments, i.e., 30 units between II and III and 34 units 
between II and IV, The possible differences are: 
iiièimv. 
Since in Phase 1 there was a significant elevation in 
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Table 17, Period comparisons and treatment differences, 
Activity in (amoles/hr/L. Phase 2, serum 
Period compared 
1 vs 3 
Period 3 minus 
Treatment Period 1 Treatment difference 
I 182 
I vs II = 110 
II 72 
II vs III = 30 
III 102 
III vs IV = 34 
IV 68 
Period 3 over Period 1 with significant treatment effect 
on this elevation, and because the response of the controls 
in Phase 2 seemed quite similar to Phase 1 (Table 18), it 
follows that there was a significant treatment effect at 
least involving Treatment II. As in Phase 1, the level of 
GDC activity of the controls was probably elevated signi­
ficantly above the baseline level. The Period 3 mean of 
Treatment IV was 24% higher than the Period 1 mean. 
The lack of significance in the test for linear trends 
in Period 2 (Table 15, Line 7) was probably due primarily 
Figure 35a. Overlay of Figure 35b. Illustrates the time period divisions and 
regression lines for each period. 
Figure 35b. Mean plot. Treatment I dogs. Phase 2, serum. 
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Figure 36b. Mean plot. Treatment II dogs. Phase 2, serum. 
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Figure 37b„ Mean plot. Treatment III dogs. Phase 2, servim. 
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Figure 38b. Mean plot. Treatment IV dogs. Phase 2, serum. 
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to the delayed GDC elevation (with flattened regression 
lines) in Treatments II, III and IV (Figures 33, 34 and 
35). The elevation of GDC activity (mean activity of 
Period 3 minus mean of Period I) of each control agreed 
fairly well with their Phase 1 counterpart (Table 18), 
However, the activity did not usually begin to increase 
in Phase 2 until 36 hours after experimental manipulation 
while in Phase 1 it usually started increasing at 12 hours 
after a drop at six hours P-S. This difference of onset 
of elevation between phases can at least partially be ex­
plained by the fact that sample 11 of all treatments was 
not collected until six hours after ischemia production 
in Treatment 1 dogs. Thus sample 11 and subsequent samples 
would be offset six hours from the P-S schedule used in 
Phase 1. The sharp decrease in activity often seen in 
Phase 1 at six hours P-S surgery could have thus been 
missed in the phase 2 controls. The impression was gained 
that the enzyme response of the controls was quite similar 
between Phases 1 and 2. The Period 2 pattern of Treatment 
1 was reminiscent of the patterns seen in Phase 1 (compare 
Figure 35 with Figure 30). 
Whereas in Period 2 the data was not obviously non­
linear, in Period 3, the straight line representation of 
the regression coefficient did not appear to represent the 
data (Figures 34 through 38). This is most easily seen in 
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Table 18. Response of controls to experimental manipulation, 
(Period 1 vs 3 comparisons). Activity in 
umoles/hr/L 
Treatment II III IV 
Phase 1 114 84 68 
Phase 2 72 102 68 
Figure 35. The data appeared to be sigmoidal rathe^ than 
linear. 
Closer examination of the Phase 2 plots (Figures 34 
through 38) revealed that the peaks and valleys of the 
plots occurred at rather consistent times after experimental 
manipulation. This consistency suggested that this particular 
position of the sigmoidal curve with respect to time was 
real. Since the serum collections and enzyme determinations 
of a., particular sample number (sampling time) for Blocks 1 
and 2 were done at an interval of one week, it seems un­
likely that these variations of activity would be due to 
variations in laboratory analysis. However, since each 
point on the Phase 2 plots was the mean of only two values, 
it is possible that these variations were due to chance. 
The fact that these peaks and valleys did not occur ab­
ruptly between adjacent sampling times but developed 
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gradually over two or three samples (the 156 hour sample 
is a consistent exception) is further evidence that the 
elevations and depressions were actual trends and that the 
sigmoidal nature of the data was real. 
The steep slope of Treatment I (b = 0,686) in Period 
2 was probably merely the elevation of the data to the 
first peak. Re-examination of the Phase 1 plots (Figures 
29 through 33) suggested that a similar situation may have 
been happening there. If the data in Phase 1 were actually 
sigmoidal, the linearity found with the totals of all dogs 
(Table 11, Line 8; Figure 29) could have been due to the 
coincidental placement of period limits near the extremes 
of a major sigmoidal deflection. 
General Comments 
The method of ischemia production used in Phase 1 did 
not produce an elevation of serum GDC activity. This 
appeared to have been related to the formation of granula­
tion tissue over the spinal cord at the axis with the sub­
sequent protection of the ventral spinal artery from 
compression. 
The lack of cord lesions and the poor clinical response 
(lack of clinical signs of brain damage) to the ischemia 
procedure in dogs 221, 311 and 321 is congruous with the 
failure of serum elevation in Period 4. The congruity broke 
down somewhac in 222 and 312 in which the clinical response 
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was interpreted as being indicative of near or slowly 
developing brain ischemia, i.e., there were severe cord 
lesions and some signs of brain ischemia but again no 
elevation of GDC. The apparent brain ischemia (based on 
the good clinical responses attained) was consistent with 
the severe cord lesions but not with the failure of serum 
GDC elevation. Since it was shown in Phase 2 that hypoxic 
brain damage was related to GDC elevation, it would seem 
that some procedural variations between phases, not ex­
plained entirely on the basis of the granulation tissue 
formation, resulted in failure of enzyme elevation in Period 
4 of Phase 1. By way of conjecture, it is suggested that 
the brains of dogs 211 and 212 and possibly dogs 222 and 
312 were in some way conditioned by surgery (e.g., vertebral 
artery ligation) to the effects of anoxia. Perhaps there 
was a reversion back to the situation in the young brain 
in which there may be more efficient utilization of endogen­
ous glycogen for anaerobic glycolysis (Dravid and Jilek, 
1965) and increased resistance to anoxia. 
The only valuable information produced by Phase 1 
came from the post-surgery period. It was found that some 
treatment caused an increase in GDC activity and there was 
a difference at least between animals in which the lamin­
ectomy was performed and the anesthesia controls. Phase 1 
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results suggested that vertebral artery ligation and 
laminectomy caused a greater elevation than laminectomy 
alone. In Phase 2, however, the reverse was true. The 
importance of vertebral artery ligation was. therefore, 
minimized. Since roughly similar enzyme patterns were 
found (Table 18) in the Phase 1 and 2 controls (Treatments 
II, III and IV), it seemed valid to malce this comparison 
between phases. 
The laminectomy procedure has been shown to be associated 
with significant cord damage and anesthesia with only very 
minor spinal cord alterations. Therefore, the possibility 
exists that the Phase 1 GDC elevation found after surgery 
could be the result of the cord damage. In this case, the 
treatment differences found would be I=II=III>IV. 
Since the Phase 1 treatment procedure had not con­
sistently produced signs of ischemia and brain damage, the 
Phase 2 method of conducting the Treatment on the same day 
as surgery was instituted. This was done to avoid rhe 
protection of the cord by the granulation tissue. To assure 
that unequivocal brain damage was produced, the common 
carotid arteries were manually ligated. 
There can be little doubt that the ischemia production 
procedure produced brain damage and resulted in marked ele­
vation of serum GDC activity. However, since the procedure 
produced extensive cord damage as well as brain damage 
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one must wonder which of the3% areas of the GNS is respons­
ible for the elevation of serum enzyme values. 
The results of this study provided only one means of 
attempting to establish whether the source of the increased 
serum enzyme was the cord or the brain. Dog 442 had signs 
and severe lesions of cord damage in the P-S period which 
were not caused by the ischemia procedure. Presumably 
brain damage had not occurred. Comparing the enzyme re­
sults of the animal with cord but not brain damage (442) 
with that of like surgical manipulation and no cord damage 
(dog 441) revealed that the enzyme elevation in Period 3 
was quite similar for the two dogs. When the data of dog 
442 were compared to those of the Treatment I dogs (421 
and 422) which had brain and cord damage it was found that 
the latter had much greater increases of GDC than the for­
mer. This indicated that the brain and not the cord damage 
was responsible for the bulk of the serum GDC elevation. 
Furthermore J GDC activity is very low in the spinal cord 
compared to the brain (Lowe et al., 1958 and Albers and 
Brady, 1959). 
The drop in GDC activity which commonly occurred at 
six to 12 hours P-S can possibly be explained on the basis 
of hemodilution. Methoxyflurane (the anesthetic agent used 
for surgery) will cause a mild transient relaxation of the 
arteriolar smooth musculature and a drop in blood pressure 
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(Goodman and Gilman, 1965), Compensation for the hypo­
tension might result in hemodilution. 
The abnormally high serum GDC activity was probably 
caused by, as is the case with other serum enzymes, its 
leakage from damaged cells. In the case of GDC, the cell 
is, quite specifically, the neuron. Under conditions of 
hypoxia, Webster and Ames (1965) found mitochondrial swell­
ing and alterations of the synapses with loss of synaptic 
vesicles. If Salganicoff and De Robertis are correct in 
their belief that GDC is concentrated in AGh-poor nerve 
endings, the GDC leakage in hypoxic damage is probably more 
specifically from the terminal end of the axone. 
Glutamate decarboxylase is apparently located in two 
(centrifugation) fractions of the cell. One fraction was 
soluble and found apparently free in the cytoplasm. The 
other fraction was apparently membrane associated (Balazs 
et al., 1966). Salganicoff and De Robertis (1965) felt 
that the latter fraction was loosely bound by Ca*^ to the 
synaptic vesicles. Van Kempen et al. (1965) suggested 
the existence of a GDC-particle. 
The bimodal distribution of the enzyme in the cell 
(Balazs, 1966) and the observation in this study of an 
apparently real double peaked sigmoidal curve provided 
grounds for qualitative speculation as to the nature 
of the release of GDC from the damaged cell. 
Oxidative phosphorylation certainly ceases during the 
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treatment if ischemia is complete. The only energy source 
then available is from anaerobic glycolysis. In ischemic 
hypoxia the exogenous source (the blood) of glucose is 
depleted and brain glycogen is then the only source of 
energy. 
The abrupt decrease in adenosine triphosphate (ATP) 
production has far reaching effects and it would seem that 
this decrease is final common pathway of most of the changes 
that occur in the cell. 
Hager (i960) suggested that there is a rise of intra­
cellular osmotic pressure and disintegration of nerve cells 
which resulted from acute hypoxia. A similar suggestion 
was made by Yap and Spector (1965). 
It seems quite feasible that the immediate effect of 
the hypoxia was to decrease the energy available to the 
cells for metabolic processes. Since the sodium pump, 
operating in the plasma membrane, requires ATP, it would be 
shutdo\i;n allowing Na to accumulate in the cell. The osmotic 
pressure would increase within the cell. This would result 
in water flow into the cell causing swelling and altered 
permeability of the membrane. The altered (increased) 
permeability of the membrane would then permit the release 
of some of the soluble cytoplasmic enzyme. This might be 
that seen in the first peak at 48 hours. 
The membrane=bound component may not be as easily 
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released from the cell until the membranes to which it is 
bound is disrupted and the cell damage is severe enough to 
allow escape of larger particles or until the enzyme is 
solubilized» At this time, most all of the cellos GDC 
would be lost. This conceivably could explain the second 
peak. 
The drop in enzyme activity at 72 hours P-T would 
be explained by degradation and/or elimination of GDC 
from the serum. 
This concept has some weaknesses. It is highly 
speculative and qualitative but, for the most part, seems 
feasible. 
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SUMMARY AND CONCLUSIONS 
1. in the studies being conducted in the Biomedical 
Engineering Program at Iowa State University on the regu­
lation of artificial heart devices, it was felt that some 
consideration should be given to the possible effect that 
the surgical procedure and maintenance of life with such 
prostheses would have on brain tissue. This investigation 
was initiated to develop and assess a method for evaluating 
the cellular response of the brain to possible insults 
incurred from survival research and clinical procedures, 
2. Various serum enzymes have been extensively 
studied and used as an aid in detecting cell or organ dam­
age, A few of these are, to a large degree, organ-speci­
fic; therefore, their elevated serum levels are a more use­
ful aid than those of more general distribution in the 
body. 
3. Glutamate decarboxylase (QDC), a pyridoxal phos­
phate- dependent enzyme, which catalyzes the conversion 
of glutamic acid to gamma amino-butyric acid (GABA), is 
apparently a central nervous system (CNS)-specific enzyme. 
It functions in CNS energy metabolism and/or in nervous 
inhibition. It is present almost exclusively in the 
grey matter of the CNSc 
4. This study undertook to produce hypoxic brain 
damage in dogs and to study the serum GDC activity levels 
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subsequent to that damage. 
5. The method of production of brain damage provided 
for the complete interruption of blood flow to the brain. 
It involved preparatory surgery in which the spinous procès 
and laminae of the axis (second cervical vertebra) were 
removed and the vertebral arteries ligated at a point anter 
ior to any known anastomoses with other vessels. Seven and 
one half days (Phase l) and six hours (Phase 2) following 
surgery, the unanesthetized dogs were entubated (tracheal) 
• " and a pneumatic pressure cuff placed around its neck over 
the axial defect. Seven hundred mm Hg pressure was instant 
aneously applied to the cuff. The success of the effect 
of the ischemia procedure to produce brain damage was eval­
uated on the basis of clinical signs of extensor rigidity 
of the legs, loss of pupillary, conjunctival and corneal 
reflexes, blindness, loss of consciousness and awareness of 
surroundings. 
6. The experiment was blocked in order to be able 
to statistically detect subtle changes in procedure which 
would be reflected in the serum enzyme values. Each block 
contained one or two dogs in which brain ischemia was 
produced (Treatment I dogs), and three types of controls. 
The first .control. Treatment II, received the complete 
surgical procedure but was not subjected to brain ischemia. 
The Treatment III dog was the second control. In this 
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control, vertebral artery ligation was deleted from the 
procedure of Treatment II^ The final control. Treatment 
IV, was the anesthesia control. Each control contained 
one dog. There were four blocks in Phase 1 and two in 
Phase 2» 
7. Blood samples were collected before initiation of 
any manipulation to establish the normal baseline serum 
GDC activity level. Extensive sampling was conducted 
after surgery and after ischemia production (treatment). 
All dogs of a block were carried through the manipulation 
and sampling schedule at the same time, 
8. The interval of 7.5 days between surgery and 
treatment was used in Phase 1 to confirm that the baseline 
had not changed as a result of surgery prior to ischemia 
production, 
9. Post mortem examination (gross and histologic) 
revealed that, at the time ischemia was produced in Phase 
1 dogs, the surgical defect had partially been replaced 
by granulation tissue. Further, various degrees of spinal 
cord damage, especially at the level of the axis, were 
found in all dogs. Severe changes were present in both 
Phase 2 and half of the Phase I dogs which were subjected 
to treatment. Laminectomy alone caused significant but 
but less severe cord lesions. Minor cord lesions were 
found in the anesthesia controls= 
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10. There was some degree of direct correlation 
between clinical response to treatment and severity of 
cord damage. The ischemia procedure did not consistently 
produce signs of brain damage in Phase Ij Treatment I dogs. 
This appeared to be partially due to the protection of the 
cord and ventral spinal artery by the granulation tissue 
from the effects of the pneumatic cuff. 
11. Using subjective logic, based upon examination 
of data from a preliminary study, the method of statistical 
analysis for the final study was decided upon and the 
sample numbers (sampling times) were divided into four time 
periods in Phase 1 and three time periods in Phase 2. 
12. The data from the serum enzyme determinations 
were statistically analyzed as a randomized block and as a 
split-plot. 
13. Various levels of significant differences were 
found between the baseline means and the post-surgery (P-S) 
as well as post-treatment (P-T) means of both phases. Also, 
linear trends were found in Phase 1 by statistical analysis. 
Some of these differences and trends were found to be 
significant at various levels for treatment (i.e., I, II 
ill or IV) effects. The analysis did not indicate which 
treatments were causing these differences. Therefore, 
subjective means of evaluating the data had to be used to 
achieve this purpose. 
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14. In Phase 1, it was found that at least the 
laminectomy caused significant elevation of GDC activity. 
This might have been caused by vertebral artery ligation 
but it appeared more likely to have resulted from surgical 
trauma to the spinal cord. Anesthesia also appeared to 
elevate the serum GDG activity but to a lesser degree, 
15. In Phase 1, the ischemia production procedure 
did not result in an elevation of the enzyme level greater 
than that found in the P-S period. This appeared to be 
partially, but not wholly, explained by the protection by 
the granulation tissue of the cord and ventral spinal 
artery from the effects of the pneumatic cuff. 
16. Phase 2 was conducted to produce unequivocal 
signs of brain damage. The ischemia production procedure 
was done on the same days as surgery to avoid the protection 
of the cord by granulation tissue. Signs of brain damage 
were pronounced and the serum GDG levels were significantly 
elevated over those of the controls. Reasons for dis­
counting the severe cord damage as a source of the bulk 
of the enzyme in the serum were given, 
17. Serum GDG activity levels have apparently not 
been studied. Normal levels of enzyme activity for five 
to six month old Beagle dogs were given. 
18. It was concluded that hypoxic brain damage 
will result in significant elevation of serum GDC activity 
and that this parameter may be useful in assessing such 
brain-damage. Further study will be necessary to evaluate 
the minimum degree of damage necessary for detectable 
increases in GDC activity to occur. 
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